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Abstract. Instrumental variable (IV) studies seek to emulate randomized encouragement designs
where patients are assigned a random nudge towards a particular treatment. Unfortunately, IV
studies may fall short of their experimental ideal due to hidden bias affecting both the proposed
instrument and the outcomes. While sensitivity analyses have been developed for IV designs most
proceed under an assumption of effect homogeneity, unlikely to hold for many applications. In our
case study on the efficacy of surgical versus non-surgical management for two gastrointestinal tract
conditions, whether or not surgery will be of greatest benefit strongly depends upon patient-specific
physiology. The validity of our proposed instrument, surgeons’ tendencies to operate, is plausible
but not ironclad, necessitating a sensitivity analysis allowing for effect variation. We present a
new sensitivity analysis accommodating arbitrary patterns of non-identified effect heterogeneity.
With binary outcomes, we prove that the conventional sensitivity analysis based on McNemar’s
test is itself asymptotically valid with heterogeneous effects. We then demonstrate that the iden-
tified components of effect heterogeneity can, when suitably exploited, improve the performance
of a sensitivity analysis through providing less conservative standard error estimators. We further
highlight the importance of heterogeneity in determining the power of a sensitivity analysis.
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21. Introduction
1.1. Emergency general surgery conditions and operative care. Emergency general surgery
(EGS) and trauma surgery are considered different forms of acute care. EGS refers to medical emer-
gencies where the injury is most often endogenous (a burst appendix) while trauma care refers to
injuries that are exogenous (a gunshot wound). Correspondingly, there are a set of medical condi-
tions known as EGS conditions that are distinct from trauma injuries (Gale et al. 2014; Shafi et al.
2013). EGS conditions affect an estimated 3-4 million patients per year and account for more than
800,000 operations in the United States alone (Gale et al. 2014; Scott et al. 2016; Havens et al.
2015; Ogola et al. 2015). Operative management is often the primary course of treatment for EGS
conditions. Surgical treatment, however, carries additional risk of complications and adverse reac-
tions to anesthesia. For many EGS conditions, non-operative care including observation, minimally
invasive procedures and supportive care may also be effective, with a lower risk of complication.
Given these competing paths for treatment, a critical clinical question faced by the acute care
community is determining the overall efficacy of surgical interventions for EGS conditions relative
to alternative courses of treatment.
We focus on the effectiveness of operative care for two common and related EGS conditions
affecting the lower gastrointestinal tract: ulcerative colitis and diverticulitis. Diverticula are marble-
sized pouches that can form in the lining of the lower part of the large intestine. Diverticulitis occurs
when one or more diverticula tear and become inflamed or infected, which causes severe abdominal
pain, fever, nausea and a marked change in bowel habits. It may be managed with rest, changes to
diet and antibiotics, but may ultimately require surgery. Ulcerative colitis is a form of inflammatory
bowel disease that causes long-lasting inflammation and ulcers in the lining of the large intestine
and rectum. The condition most often begins gradually and can become worse over time and
lead to life-threatening complications. Like diverticulitis, colitis may be managed through diet and
medications, but may require surgery to remove sections of the intestine.
One challenge in studying the effectiveness of surgery for these EGS conditions is that randomized
comparisons between surgical and non-surgical care are generally judged to violate the principle of
clinical equipoise. Evidence on the effectiveness of procedures for EGS conditions must instead be
collected from observational studies, which introduces potential biases into resulting analyses due
3to the non-random determination of the assigned treatment. Unsurprisingly, patients who undergo
emergency operative treatment are often the sickest patients (Shafi et al. 2013). While statistical
adjustment for measures of patient frailty may render treated and control groups comparable,
such adjustments are often insufficient due to both inadequacies in observed covariates and the
potential presence of hidden biases (Keele et al. 2019a). Faced with such biases, one alternative
is to search for “natural experiments” where an intervention is judged to be allocated in an as-
if random fashions. While exploiting these “gifts of nature” (Rosenzweig and Wolpin 2000, pg.
872) requires considerable care, results from natural experiments are often compelling despite the
absence of active randomization (Angrist and Pischke 2010; Dunning 2012).
1.2. Physician preference as an instrument in comparative effectiveness research. The
instrumental variable (IV) method is one form of natural experiment exploiting haphazard nudges
towards treatment exposure. An IV is a variable that is associated with the treatment of interest,
but affects outcomes only indirectly through its impact on treatment assignment (Angrist et al.
1996). One frequently proposed instrument in comparative effectiveness research is a physicians’s
preference for a specific course of treatment. Here, it is assumed that for a patient of a given
level of disease severity, physicians may differ in their preferred course of treatment for primarily
idiosyncratic reasons. Thus, when a patient receives care from a physician with a specific set of
treatment preferences, it is assumed they are being exposed to an as-if randomized encouragement
towards that treatment. Brookhart et al. (2006) first used this type of IV in the context of drug
prescriptions. See Davies et al. (2013) for examples and Brookhart and Schneeweiss (2007) for an
overview.
We consider surgeon’s preference for operative management as a candidate instrument for whether
a specific patient with a diagnosis of colitis or diverticulitis receives surgery after admission to the
emergency department. We measure each surgeon’s preference for operative management with data
on how they manage care for EGS conditions. For each surgeon in our data, we have information
on whether or not a surgeon operated for patients with 51 acute EGS conditions. Following Keele
et al. (2018), we use this information to construct a measure of a surgeon’s tendency to operate
(TTO) by calculating the percentage of times a surgeon operates when presented with an EGS
condition. For the surgeons in the data, TTO–expressed as percentage–varied from less than 5% to
495%. Consider two patients in the emergency department with diverticulitis with similar baseline
characteristics. One might receive care from a surgeon that tends to operate (higher TTO), while
another might receive care from a surgeon that is more likely to recommend non-surgical manage-
ment (lower TTO). Being assigned to a patient with a higher or lower tendency to operate may
then be viewed nudge towards or away from surgery (Keele et al. 2018). Since these are emergency
admissions, it is unlikely that patients themselves are selecting their surgeon. Instead, this suggests
that assignment to surgeon with a specific TTO is a plausibly haphazard process, with clear impact
on whether or not a patient receives operative care.
Our data set merges the American Medical Association (AMA) Physician Masterfile with all-
payer hospital discharge claims from New York, Florida and Pennsylvania in 2012-2013. The study
population consists of all patients admitted for inpatient care emergently, urgently, or through the
emergency department during that time period in those states. The data include an identifier for
each patient’s surgeon, along with patient sociodemographic and clinical characteristics including
indicators for frailty, severe sepsis or septic shock, and 31 comorbidities based on Elixhauser indices
(Elixhauser et al. 1998). The data also include measures of the surgeon’s age and years experience.
Surgeons were excluded from the cohort if they did not perform at least 5 operations for one of the
51 specific EGS conditions per year within the two-year study time-frame. All told, this resulted in
N = 44, 082 patients presenting with either colitis or diverticulitis. We use three different measures
for health outcomes. We also investigate whether the presence of sepsis (an inflammatory response
to infection that can result in organ malfunction) acts as a modifier for the effect of surgery.
Our primary outcome was the presence of any in-hospital complication (infection, bleeding) as
measured by a binary variable. Secondary outcomes are hospital length-of-stay; and in-hospital
mortality within 30 days after admission. Mortality was treated as a secondary outcome, as deaths
for patients with a colitis or diverticulitis diagnosis are rare. To our knowledge, this is the first
study based on IV methods that provides evidence on the effectiveness of operative management
for these two conditions.
1.3. Probing the robustness of an instrumental variable analysis. In order for a surgeon’s
tendency to operate to be a valid instrument, one must assume that there are no lurking variables
which simultaneously influence the value of TTO for the surgeon assigned to a patient and the
5patient’s health outcomes. Suppose instead that surgeons with higher TTO are precisely the more
skilled surgeons. Were this the case, and if patients most in the most dire straits were assigned
to the most skilled surgeons, then TTO’s status as an instrumental variable would be undermined
and the resulting estimate of surgery’s efficacy in managing colitis and diverticulitis may be biased.
While the data include measures of surgeon age and experience, these are imperfect measures
of surgical skill, such that even after adjusting for these measures a critic of the study may be
unconvinced that bias has been removed.
Such suspicions of residual bias motivate sensitivity analyses for IV studies. A sensitivity analysis
asks how strong the impact of a hidden bias would have to be on the instrumental variable to alter
the substantive conclusions from the study. Rosenbaum (1996) first proposed a sensitivity analysis
for the possibility of hidden bias in instrumental variable studies. Existing methods for sensitivity
analysis in an IV design share a common limitation: they are derived under the assumption of
a pre-specified model of effects for each individual in the observational study. By far the most
prevalent model for effects under these approaches is that of proportional doses - i.e. that the
difference in potential outcomes under encouragement to treatment versus encouragement to control
is proportional to the difference in treatment actually received under encouragement to treatment
versus encouragement to control (Rosenbaum 2002a; Imbens and Rosenbaum 2005). This model
is reviewed in §3.2. In our example, with respect to length of stay, this would imply the hospital
length of stay that would have been observed if assigned to a surgeon with a high versus low TTO
would be proportional to the difference in whether or not surgery would actually be performed
on that individual when assigned to a high versus low TTO surgeon, and further that the same
proportionality constant holds across all individuals. This would imply that all patients who would
undergo surgery if and only if assigned to a surgeon with a high TTO have the same treatment
effect. Furthermore, with binary outcomes such as our complication outcome, the only plausible
value for this effect would be zero.
The effect homogeneity implied by this model seems at odds with the possibility of essential
heterogeneity. Essential heterogeneity refers to the possibility that individuals select treatments
based on expected idiosyncratic gains or losses from treatments. For example, essential heterogene-
ity would be present if patients opt for or against surgery based on their belief of which treatment
6would furnish the largest benefit. Were patients correct in their beliefs, one would then expect
surgery to have a positive effect relative to non-surgical alternatives on those selecting into surgery,
and a negative effect on those who received the non-surgical alternatives. Many argue that essential
heterogeneity is a key feature of the IV framework (Heckman et al. 2006), and a suspicion that
essential heterogeneity may be present would call into question the utility of a sensitivity analysis
conducted under the proportional dose model.
1.4. The roles of effect heterogeneity in randomization-based sensitivity analysis. Treat-
ment effect heterogeneity refers to variation in the effects of an intervention across individuals.
While some of this variation may be ascribed to intrinsically random variation, a portion of it may
well be predictable on the basis of observed covariates known as effect modifiers. Heterogeneity in
effects is plausible if not certain in our application, as the degree of risk associated with surgery is
dependent upon to patient-specific physiology. Presence of sepsis upon presentation to a surgeon
is just one factor that might influence whether surgery would be beneficial relative to non-surgical
alternatives.
Treatment effect heterogeneity has both identified and nonidentified components. Using our
investigation of EGS outcomes as a case study, we illustrate the varied roles that these components
can play in the analysis of matched instrumental variable studies. In addressing the potentially
pernicious nonidentified aspects of effect heterogeneity, we present a sensitivity analysis for matched
IV studies that is exact under the proportional dose model but is asymptotically correct for a much
weaker null hypothesis on a parameter known as the effect ratio (Baiocchi et al. 2010; Kang et al.
2016), the ratio of the average effects of encouragement on the potential outcomes to encouragement
on the treatment received without specifying the individual-level treatment effects. This method
obviates concerns that the nonidentified components of effect heterogeneity may conspire with
hidden bias to render attempts at sensitivity analysis insufficient. We compare our methods with
existing approaches for sensitivity analysis in matched IV studies justified under more restrictive
models of effects. In the particular case of binary outcomes, we prove that the suggested method
for sensitivity analysis of Baiocchi et al. (2010) using McNemar’s test, justified therein only under
Fisher’s null of no treatment effect, is a special case of our method and hence also provides an
7asymptotically correct sensitivity analysis for the null of no effect ratio while allowing for patient-
specific heterogeneity.
Next, we use our clinical application to EGS outcomes to highlight the roles that the identified
aspects of effect heterogeneity can play in improving the performance of a sensitivity analysis. We
develop improved standard error estimates for use within a sensitivity analysis with heterogeneous
effects. These standard errors are valid regardless of the truth of an underlying model for effect
modification as a function of observed covariates, but provide more substantial gains should the
posited model of effects motivating them prove correct. By further comparing results of our analysis
between the sepsis and non-sepsis subgroups, we provide an illustration of the role that latent
heterogeneity can play in the resulting power of a sensitivity analysis as originally discussed in
Rosenbaum (2005). In an analysis assuming no hidden bias, the power of a test of no treatment
effect when one is actually present tends to one in the limit so long as the effect is identified.
Contrary to this, a sensitivity analysis’ limiting power under non-local alternatives depends not
upon the magnitude of the treatment effect itself, but rather upon its magnitude relative to the
degree of heterogeneity within matched sets. Perhaps surprisingly, a sensitivity analysis may be less
able to discriminate bias from treatment effect in a subgroup with a larger treatment effect than a
subgroup with a smaller treatment effect even asymptotically should the subgroup with the larger
effect also have a larger degree of heterogeneity. That is to say, if subgroup 1 has a larger treatment
effect than subgroup 2, a sensitivity analysis may nonetheless have limiting power 0 to detect the
effect in subgroup 1, but limiting power 1 in subgroup 2. Exploiting the identified components
can substantially benefit the resulting sensitivity analysis, while the unidentified components are
rendered innocuous by the methods developed here.
2. A matched instrumental variable study and its experimental ideal
2.1. A near-far match. It is well documented that stronger instruments provide both more infor-
mative effect estimates and estimates that are more resistant to hidden bias, providing motivation
to actively strengthen an instrument as part of the analysis (Small and Rosenbaum 2008). One ap-
proach for strengthening an instrument is a near-far matched design (Baiocchi et al. 2010). Near-far
8matching creates matched pairs that are similar in terms of observed covariates but highly dissim-
ilar on the values of the instrument. We use a form of near-far matching that combines refined
covariate balance with near-far matching (Pimentel et al. 2015; Keele et al. 2019b). This allows
us to both balance a large number of nominal covariates viewed to be of clinical importance while
maintaining a large distance between pairs on the instrumental variable.
Each matched pair is exactly matched on both hospital and an indicator of sepsis, such that
across-hospital differences in quality of care and fundamental differences in physiology between
septic and non-septic patient cannot bias the analysis. For the remaining covariates, we minimized
the total of the within-pair distances on covariates as measured by the Mahalanobis distance and
applied a caliper to the propensity score. We further applied near-fine balance constraints for three
indicators for surgical volume at the hospital at the time of admission and a dummy variable for
whether a patient had a specific disability. Fine balance constrains two groups to be balanced on a
particular variable without restricting matching on the variable within individual pairs (Rosenbaum
et al. 2007). A near-fine balance constraint returns a finely balanced match when one is feasible, and
otherwise minimizes the deviation from fine balance (Yang et al. 2012). As a result, the marginal
distribution for these three indicators will be exactly or nearly exactly the same across levels
of the IV. Finally, we also applied optimal subsetting to discard matched pairs with high levels
of imbalance on covariates (Rosenbaum 2012). After matching, we calculated the standardized
difference for each covariate, which is the mean difference between matched patients divided by
the pooled standard deviation before matching. In the match, we attempted to produce absolute
standardized differences of less than 0.10, a commonly recommended threshold (Rosenbaum 2010).
Table 1 contains balance statistics before and after matching on selected covariates. In general,
balance even before matching is quite good: none of the absolute standardized differences exceed
0.20, and only six exceed 0.10. Matching moved most absolute standardized differences below 0.1,
suggesting that matching was successful in attenuating potential biases due to discrepancies in
observed surgeon characteristics and available data on patient physiology. From the perspective of
observed covariates, Table 1 suggests that surgeons with high versus low TTO appear to have been
assigned to patients in a haphazard, asystematic manner.
9Table 1. Covariate balance before and after matching. Instrument split into high
versus low categories at the average value for TTO. St. Dif. = standardized differ-
ence
Unmatched Data Matched Data
N=44,082 N=18,062
High TTO mean Low TTO Mean St. Dif. High TTO mean Low TTO Mean St. Dif.
Age 63.48 65.24 -0.11 68.21 68.13 0.01
No. Comorbidities 3.09 3.11 -0.01 3.99 3.96 0.01
Surgeon Age 54.16 52.95 0.12 53.02 51.63 0.15
Surgeon Experience (Years) 17.07 15.45 0.16 15.59 14.70 0.09
Female 0.52 0.55 -0.07 0.56 0.56 0.00
Hispanic 0.11 0.12 -0.04 0.08 0.09 -0.03
White 0.80 0.73 0.17 0.76 0.76 0.00
African-American 0.10 0.15 -0.13 0.13 0.13 -0.00
Other Racial Cat. 0.09 0.12 -0.09 0.11 0.11 0.00
Sepsis 0.29 0.24 0.11 0.38 0.38 0.00
Disability 0.07 0.08 -0.06 0.10 0.10 0.00
Select Comorbidities
Congestive Heart Failure 0.15 0.15 -0.02 0.25 0.23 0.05
Cardiac Arrhythmias 0.26 0.23 0.06 0.37 0.35 0.04
Valvular Disease 0.07 0.07 0.01 0.12 0.10 0.07
Pulmonary Circulation Disorders 0.05 0.04 0.01 0.08 0.07 0.03
Peripheral Vascular Disorders 0.08 0.07 0.06 0.10 0.11 -0.02
Hypertension, Uncomplicated 0.43 0.45 -0.02 0.44 0.45 -0.02
Paralysis 0.02 0.01 0.03 0.03 0.02 0.01
Other Neurological Disorders 0.08 0.08 0.00 0.13 0.11 0.06
Chronic Pulmonary Disease 0.22 0.22 -0.00 0.27 0.26 0.04
Diabetes, Uncomplicated 0.17 0.21 -0.09 0.22 0.23 -0.01
Diabetes, Complicated 0.05 0.04 0.02 0.06 0.07 -0.02
Hypothyroidism 0.13 0.13 -0.01 0.15 0.15 -0.00
Renal Failure 0.15 0.17 -0.05 0.24 0.26 -0.04
Liver Disease 0.04 0.06 -0.07 0.05 0.06 -0.06
Peptic Ulcer, Excl. Bleeding 0.01 0.02 -0.06 0.01 0.01 0.03
Hypertension, Complicated 0.14 0.16 -0.03 0.22 0.24 -0.03
2.2. Notation for randomized encouragement designs and instrumental variable stud-
ies. We now introduce notation for the experimental design that near-far matching emulates. To
assist the reader, essential notation and definitions introduced here and elsewhere are summa-
rized in §A of the appendix. There are 2n individuals partitioned into n matched pairs. Each
pair contains one individual encouraged to take the treatment, denoted Zij = 1, and one individ-
ual not encouraged to take the treatment (Zij = 0). In our study, the patient assigned to the
surgeon with the higher value of the instrumental variable TTO in each pair is the patient for
whom Zij = 1. Individual ij has two potential responses: one under encouragement to treatment,
yij(1), and the other under no encouragement, yij(0). Further, individual ij has two values for
the level of treatment actually received: that under encouragement, dij(1), and under no encour-
agement, dij(0). In this work we will consider binary values for dij(z) for z = 0, 1, such that
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dij(z) represents whether or not an individual would actually take the treatment when assigned
encouragement level z. That said, the methods we develop readily extend to the case of continuous
dij(z). The observed outcome and exposure are Yij = yij(Zij) and Dij = dij(Zij) respectively. Let
F = {yij(1), yij(0), dij(1), dij(0),xij , uij : i = 1, . . . , n; j = 1, 2}, where xij represent the observed
covariates for each individual and uij is an unobserved covariate 0 ≤ uij ≤ 1. While a univariate
hidden variable constrained to the unit interval may appear restrictive, in fact there always exists
a hidden variable between 0 and 1 such that if the practitioner had access to it, adjustment for it
would be sufficient for identifying a causal effect (Rosenbaum 2017, §9, footnote 15). We consider
finite-population inference moving forwards, which will be reflected by conditioning upon F in
the probabilistic statements that follow. Hence, inferential statements will pertain to parameters
defined in the observed study population, without dependence upon the existence of a hypothet-
ical superpopulation. Let Z = (Zi1, Zi2, ..., Zn2)
T , and let boldface similarly denote other vector
quantities such as u = (ui1, ui2, ..., un2)
T .
Patients in our study are placed into pairs using observed covariates xij such that xi1 ≈ xi2.
Despite this, paired subjects may not be equally likely to be exposed to a high versus low value
of the instrument due to discrepancies on an unobserved covariate, i.e. ui1 6= ui2. Let Ω =
{z : zi1 + zi2 = 1} be the set of the 2n possible values z of Z, and let Z denote the event
{Z ∈ Ω}. In finite-population causal inference the only source of randomness is the assignment of
the encouragement Zij . Were Z chosen uniformly from Ω as in a randomized experiment, we would
have Pr(Z = z | F ,Z) = 1/|Ω| for each z ∈ Ω, where |A| is the number of elements of a finite set
A.
2.3. A model for biased encouragements. While assignment of patients to surgeons of varying
tendencies to operate may have appeared haphazard on the basis of observed covariates, matching
can do nothing to preclude hidden biases from influencing effect estimates and hypothesis tests.
We employ the model for a sensitivity analysis from Rosenbaum (2002b, §4), which parameterizes
the impact of hidden biases on the probabilities of encouragement within a matched set. Let
piij = Pr(Zij = 1 | F). The model proposes that for individuals j and k in the same matched set i,
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piij and piik may differ in the odds ratio scale by at most Γ ≥ 1,
1
Γ
≤ piij(1− piik)
piik(1− piij) ≤ Γ. (1)
Returning attention to the paired structure by conditioning upon Z, (1) is equivalent to assuming
1/(1 + Γ) ≤ Pr(Zij = 1 | F ,Z) ≤ Γ/(1 + Γ) for i = 1, . . . , n; j = 1, 2. In the context of our study,
equation (1) suggests that before matching and without conditioning on the matched structure,
patients with similar observed covariates could differ in their odds ratio of being assigned to a
surgeon with a high TTO by at most Γ. Conditioning on the matched structure, the probability
that a given patient in a matched set was assigned to a surgeon with high TTO given that exactly
one of the two patients in that matched set were assigned to a high TTO patient falls between
1/(1+Γ) and Γ/(1+Γ). Γ = 1 corresponds to a randomized encouragement design (Holland 1988),
while pushing Γ beyond one allows unmeasured confounding to increasingly bias the encouragement
to treatment.
3. Existing modes of inference for the effect ratio
3.1. The effect ratio and its interpretation. We consider inference for an estimand known as
the effect ratio,
λ =
∑n
i=1
∑2
j=1{yij(1)− yij(0)}∑n
i=1
∑2
j=1{dij(1)− dij(0)}
, (2)
where it is assumed that
∑n
i=1
∑2
j=1{dij(1)−dij(0)} > 0. The effect ratio is the ratio of two average
treatment effects. In our application, the treatment effect in the numerator is the effect of being
assigned to a surgeon with high versus low TTO on any one of the health outcomes of interest.
The treatment effect in the denominator is the effect of surgeon TTO on whether or not a patient
has surgery. Under perfect compliance, dij(1) − dij(0) = 1 for all individuals and λ would be the
sample average treatment effect for the individuals in our matched study.
Angrist et al. (1996) discuss how additional assumptions about the treatment actually received
and the potential responses justify alternative interpretations for the effect ratio. When dij(z) are
binary for z = 0, 1, individuals fall into four different classes: compliers, always-takers, never-takers,
and defiers. Compliers are patients who are exposed to surgery if they were encouraged by the IV
but would not otherwise have surgery. Always-takers have surgery regardless of assigned IV status,
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and never-takers are never exposed to surgery regardless of IV status. Defiers are patients who are
only exposed to the treatment (surgery) if not encouraged or are unexposed if encouraged. Suppose
one is willing to assume that (1) dij(1) ≥ dij(0), known as monotonicity; and (2) dij(1)− dij(0) =
0⇒ yij(1)− yij(0) = 0, the exclusion restriction. Assumption (1) implies that there are no defiers,
while assumption (2) implies that the encouragement only affects the potential outcomes through
altering the treatment actually received. Under these assumptions, λ may be interpreted as the
sample average treatment effect among compliers, i.e. the individuals who would undergo surgery if
and only if assigned to a surgeon with a higher preference for surgery. Small et al. (2017) describe
a relaxation of monotonicity called stochastic monotonicity which may be more appropriate for
IV studies using physician preference as an instrument. Under stochastic monotonicity, λ instead
refers to a weighted average treatment effect where individuals more strongly influenced by the
encouragement receive larger weight. Inferences for the effect ratio λ are valid regardless of these
assumptions when interpreted solely as a ratio of two treatment effects, but one is entitled to
additional interpretations should further assumptions be made.
Assuming validity of the instrumental variable, i.e. that (1) holds at Γ = 1, Baiocchi et al. (2010)
provide a large-sample method for constructing confidence intervals and performing inference for
the effect ratio under effect heterogeneity. Using the method of Baiocchi et al. (2010), Table 2
shows estimated effect ratios for septic and non-septic patients on our three surgical outcomes:
mortality, presence of a complication after the administered course of treatment, and hospital
length of stay. To contextualize the effect ratio in this case, the effect ratio for length of stay
for septic patients estimates the ratio of the average effects of being assigned to a high versus
low tendency to operate surgeon on (a) the length of stay in the hospital to (b) whether or not
the patient actually underwent surgery. Assuming monotonicity and the exclusion restriction, the
estimand can further be interpreted as the average effect of surgery on hospital length of stay for
the subset of individuals who would undergo surgery if and only if assigned to a surgeon with a
higher preference for surgery. Under these assumptions, we find that among compliers who are
non-septic, the estimated difference in the percentage of complications had all patients undergone
surgery versus had all patients undergone non-surgical management is 12% (favoring non-surgical
alternatives). For septic patients complying with their encouragement, this risk difference is 25%
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(favoring non-surgical alternatives). While the method yielding the estimates in Table 2 is valid
under heterogeneous effect under the assumption of no hidden bias, lurking variables such as innate
surgeon ability or unobserved patient health characteristics may have resulted in bias in these
IV estimates. We now describe existing methods for sensitivity analysis in instrumental variable
studies, and note their apparent inability to accommodate arbitrary patterns of effect heterogeneity.
Table 2. Estimated effect of surgery on EGS patient outcomes based the effect
ratio. Point estimates for binary outcomes are risk differences expressed as percent-
ages. Brackets contain 95% confidence intervals attained by inverting the test of
Baiocchi et al. (2010).
Septic Patients Non-septic Patients
Complication
25.3 12.0
[ 19.3 , 31.4 ] [ 8.3 , 15.7 ]
Length of Stay
6.8 4.1
[ 4.4 , 9.2 ] [ 3.4 , 4.8 ]
Mortality
1.96 0.59
[ -1.9 , 5.9 ] [ -0.5 , 1.6 ]
3.2. Sensitivity analysis for the effect ratio with effects proportional to dose. Rosen-
baum (1996) and Rosenbaum (2002b, §5.4) develop methods for exact sensitivity analyses in paired
instrumental variable studies under the proportional dose model, which states
H(λ0)prop : yij(1)− yij(0) = λ0{dij(1)− dij(0)}, i = 1, . . . , n; j = 1, 2.
This naturally extends the model of constant effects commonly employed in randomized experiments
to the case of randomized encouragement designs. If an individual complies with their encouraged
treatment then yij(1)− yij(0) = λ0, while if an individual defies their encouragement then yij(1)−
yij(0) = −λ0 as dij(1) − dij(0) = −1. If the encouragement does not influence the treatment
received, yij(1)−yij(0) is set to zero and hence the exclusion restriction holds. Under this model, a
sensitivity analysis proceeds by finding the worst-case inference for a particular Γ in (1). One then
iteratively increases the value of Γ until the null hypothesis can no longer be rejected. Baiocchi
et al. (2010) describe how McNemar’s test can be used for the particular null hypothesis H
(0)
prop with
binary outcomes.
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The proportional dose model may be considered overly restrictive for certain instrumental vari-
able studies. In particular, it implies that all individuals who would comply with their assigned
encouragement have an identical treatment effect λ, which precludes essential heterogeneity among
other forms of effect heterogeneity. Furthermore, for binary outcomes, the only value of λ for
which the model is plausible is λ = 0, amounting to an assumption of Fisher’s sharp null that the
encouragement has no effect for any individual. Given the apparent limitations of the proportional
dose model in the presence of heterogeneous treatment effects, a more attractive form of sensitivity
analysis might instead focus on the weaker null hypothesis
H
(λ0)
weak : λ = λ0.
The hypothesis H
(λ0)
weak is a composite hypothesis, testing all possible combinations of potential
outcomes that satisfy λ = λ0. This hypothesis does not require any further pre-specification of the
individual level potential outcomes or doses received. The proportional dose hypothesis H
(λ0)
prop is
simply one element of H
(λ0)
weak, and need not yield the supremum p-value over the composite null
when conducting a sensitivity analysis. See Baiocchi et al. (2010) for more on the relationship
between H
(λ0)
prop and H
(λ0)
weak.
4. Sensitivity analysis for the effect ratio
4.1. A valid approach with heterogeneous effects. We now develop a sensitivity analysis for
testing H
(λ0)
weak in paired instrumental variable designs. Observe that under the null hypothesis,
(2n)−1
∑n
i=1
∑2
j=1[yij(1)− yij(0)− λ0{dij(1)− dij(0)}] = 0. Define ζ(λ0)i = (Zi1 −Zi2){Yi1 − Yi2 −
λ0(Di1−Di2)} as the encouraged-minus-non encouraged differences in the terms Yij−λ0Dij , which
may be thought of as the observed outcome adjusted for the treatment level received for each indi-
vidual ij. Observe that at Γ = 1, E(ζ
(λ0)
i | F ,Z) = (1/2)
∑2
j=1[yij(1)−yij(0)−λ0{dij(1)−dij(0)}],
and that n−1
∑n
i=1 ζ
(λ0)
i hence forms an unbiased estimating equation for λ0 in a randomized en-
couragement design. Further observe that under H
(λ0)
prop, the absolute value |ζ(λ0)i | is fixed across ran-
domizations, with only its sign varying. This observation underpins the use of permutation-based
methods for sensitivity inference described in Rosenbaum (2002b); however, for other elements of
H
(λ0)
weak, the value of |ζ(λ0)i | may itself be random over z ∈ Ω.
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Suppose one wants to conduct a sensitivity analysis for whether the effect ratio equals λ0 at level
of unmeasured confounding Γ without assuming proportional doses. Define LΓi as
LΓi = ζ
(λ0)
i −
(
Γ− 1
1 + Γ
)
|ζ(λ0)i |.
Based upon the n random variables LΓi, define se(L¯Γ) to be the conventional standard error for a
paired design,
se(L¯Γ)
2 =
1
n(n− 1)
n∑
i=1
(LΓi − L¯Γ)2,
and consider using as a test statistic with a greater-than alternative T (Z,Y − λ0D) = L¯Γ/se(L¯Γ).
With our test statistic defined, attention now shifts towards the construction of a reference
distribution for the sensitivity analysis. When testing with a greater-than alternative, the sensitivity
analysis focuses bounding the upper-tail probability for the employed test statistic. Let VΓi take
values ±1 with pr(VΓi = 1 | F ,Z) = Γ/(1 + Γ), and define the random variable BΓi as
BΓi = VΓi|ζ(λ0)i | −
(
Γ− 1
1 + Γ
)
|ζ(λ0)i |.
The construction of BΓi is motivated by the proportional dose model: under H
(λ0)
prop, BΓi stochasti-
cally dominates LΓi if (1) holds at Γ. Despite the fact that we are testing the weaker null H
(λ0)
weak
consider using as a reference distribution the distribution of B¯Γ/se(B¯Γ) given |ζ(λ0)|. In other
words, we employ the randomization distribution of the test statistic L¯Γ/se(L¯Γ) imagining that the
proportional dose model held, and setting the assignment probabilities equal to those that stochas-
tic bound LΓi under that model. The decision whether or not to reject the null hypothesis in a
sensitivity analysis at Γ using the studentized statistic L¯Γ/se(L¯Γ) is
ϕ(λ0)(α,Γ) = 1{L¯Γ/se(L¯Γ) ≥ G−1Γ (1− α)}, (3)
where G−1Γ (q) = inf{k : GΓ(k) ≥ q} is the qth quantile of the distribution of B¯Γ/se(B¯Γ) given
|ζ(λ0)|. See Algorithm 2 of Fogarty (2019) for more on constructing GΓ(·), with his τˆi replaced by
ζ
(λ0)
i .
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Proposition 1. Suppose that H
(λ0)
weak is true and that (1) holds at Γ. Then, under mild regularity
conditions and for α ≤ 0.5,
lim
n→∞E(ϕ
(λ0)(α,Γ) | F ,Z) ≤ α.
The procedure ϕ(λ0)(α,Γ) provides an asymptotically valid sensitivity analysis for the effect ratio
λ. Under the additional assumptions of monotonicity and the exclusion restriction, ϕ(λ0)(α,Γ)
would also be a valid sensitivity analysis for the sample average treatment effect among compliers.
The proof of Proposition 1 mirrors that of Theorem 2 in Fogarty (2019) and is sketched in the
appendix. For testing the null hypothesis on the effect ratio without assuming proportional doses,
regularity conditions are required to ensure that n× se(L¯Γ)2 converges in probability to a limiting
value, and that a central limit theorem applies to
√
nL¯Γ.
Remark 1. Analogous arguments to those presented in Fogarty (2019, §4.3) imply that one attains
a sensitivity analysis that is asymptotically correct under H
(λ0)
weak and finite-sample exact under
H
(λ0)
prop by replacing L¯Γ/se(L¯Γ) and B¯Γ/se(B¯Γ) with max{0, L¯Γ/se(L¯Γ)} and max{0, B¯Γ/se(B¯Γ)}.
Recalling that we have motivated our test with a greater than alternative in mind, this truncation
is unlikely to matter in practice. A sensitivity analysis based upon L¯Γ/se(L¯Γ) would only fail to be
finite-sample exact should the critical value generated by the employed reference distribution fall
below 0. In the limit, this would only occur if the investigator desired inference at a level α ≥ 0.5,
a rare choice for most any application.
Remark 2. At Γ = 1, our method is asymptotically equivalent to that of Baiocchi et al. (2010).
The test statistic proposed in that work for inference at Γ = 1 is precisely L¯1/se(L¯1), and the
methods differ solely in the reference distribution employed. Baiocchi et al. (2010) use the Normal
distribution, while our approach uses a reference distribution generated by biased permutations
of the observed data under the assumption of proportional doses in order to maintain exactness
under that model for effects. Under suitable regularity conditions our reference distribution GΓ(k)
converges in probability to Φ(k), the CDF of a standard Normal, pointwise at all points k. Their
method can be viewed as a large-sample approximation of our method at Γ = 1, and replacing our
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reference distribution GΓ(k) at Γ > 1 with the standard Normal Φ(k) would provide the natural
extension of their large-sample approach for inference on the effect ratio to a sensitivity analysis.
4.2. Binary responses: Equivalence with McNemar’s test and testing nonzero nulls.
After introducing the effect ratio and developing large-sample inference for it at Γ = 1, Baiocchi
et al. (2010) suggest conducting a sensitivity analysis based on McNemar’s test while restricting
attention to the narrower null hypothesis H
(0)
prop. One may be concerned that the sensitivity anal-
ysis using McNemar’s test would be misleading if instead H
(0)
weak held, such that the effect ratio
equalled zero but Fisher’s sharp null did not hold. As we now demonstrate, such concerns are not
warranted. In fact, McNemar’s test is equivalent to the test ϕ(0)(α,Γ) presented in the previous
section, and hence also provides a sensitivity analysis that is both finite-sample exact for H
(0)
prop and
asymptotically correct for H
(0)
weak.
Proposition 2. Suppose that outcomes are binary and one employs a sensitivity analysis based on
McNemar’s test statistic,
TM (Z,Y) =
n∑
i=1
ZijYij ,
using its worst-case distribution under the assumption of H
(0)
prop as described in Rosenbaum (1987)
and Baiocchi et al. (2010). Denote the resulting candidate level−α sensitivity analysis by ϕM (α,Γ).
Then, for any observed vector Z ∈ Ω and any vector of binary responses Y,
ϕM (α,Γ) = ϕ
(0)(α,Γ).
That is, the two sensitivity analyses are equivalent, furnishing identical p-values for all Γ.
Corollary 1. If (1) holds at Γ, outcomes are binary, and H
(0)
weak holds,
lim
n→∞E(ϕM (α,Γ) | F ,Z) ≤ α
The proof of Proposition 2 is presented in the appendix, and requires showing that over elements
of Ω, L¯Γ/se(L¯Γ) is a strictly increasing function of McNemar’s statistic TM (Z,Y) =
∑n
i=1 ZijYij ,
the number of encouraged individuals for whom an event occurred. The statistics then have perfect
rank correlation over z ∈ Ω, implying identical p-values for any data set. Because ϕ(0)(α,Γ) is valid
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under the weak null, the sensitivity analyses for binary outcomes presented in Baiocchi et al. (2010),
motivated under Fisher’s sharp null, is also an asymptotically correct sensitivity analysis for the
effect ratio equaling zero in the presence of effect heterogeneity. Indeed, any sensitivity analysis
conducted using McNemar’s test statistic is not only exact for Fisher’s sharp null, but is also
asymptotically correct for the null of no average effect in the study population. Sensitivity analyses
using McNemar’s tests are ubiquitous in paired observational studies with binary outcomes, and
Proposition 2 provides a useful fortification for those analyses should a critic be concerned about
effect heterogeneity.
The equivalence with McNemar’s test pertains to the particular test that the effect ratio equals
zero. Observe that the procedure ϕ(λ0)(α,Γ) remains asymptotically valid for testing H
(λ0)
weak for
λ0 6= 0 even with binary outcomes. Owing to this, the test ϕ(λ0)(α,Γ) can be inverted to provide
asymptotically valid sensitivity intervals for the effect ratio with binary outcomes.
4.3. Application to the study of surgical outcomes for EGS patients. Using these devel-
opments, we now perform a sensitivity analysis for our study. As previously discussed, at Γ = 1
our IV analysis assumes that patients are assigned to surgeons in an as-if random fashion after
accounting for observed covariates. Since our data do not truly stem from a randomized encour-
agement design, we cannot rule out the presence of hidden bias from IV–outcome confounders. We
assess whether our results are sensitivity to this form of hidden bias. In Table 3, we summarize the
sensitivity analysis using the sensitivity value – the value of Γ at which the estimate is no longer
statistically significant at the 0.05 level (Zhao 2019).
Table 3. Sensitivity analysis for the estimated effect of surgery on EGS patient
outcomes. Cell entries are sensitivity values when testing at α = 0.05, the largest
values of Γ for which the null of zero effect ratio is rejected (Zhao 2019).
Septic Patients Non-septic Patients
Complication 1.56 1.59
Length of Stay 1.64 2.36
Mortality 1.00 1.00
Table 3 illustrates that when effect modification is present, hypothesis tests for different sub-
groups may vary not only in their degree of statistical significance assuming Γ = 1, but also in their
sensitivity to bias should the test at Γ = 1 reject. For related results, see also Hsu et al. (2013)
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and Lee et al. (2018). We find that is true with respect to sepsis. While the point estimates are
larger for the septic patients as displayed in Table 2, the Γ changepoint values are larger in the
non-septic group for both complication and hospital length of stay. Specifically, in the IV analysis,
for septic patients the changepoint value is 1.64, while it is 2.36 for non-septic patients. To put
this in perspective, for septic patients an unobserved covariate would have to increase the odds
of treatment by a surgeon with a high TTO by a factor of 1.64 within matched pairs in order to
overturn our finding of a positive effect ratio at α = 0.05. In contrast, for non-septic patients an
unobserved covariate would have to increase the odds of treatment by a high TTO surgeon by a
factor of 2.36 in order to overturn the finding of a positive effect ratio among this subgroup.
Sepsis is but one of many patient-level health characteristics which might reasonably influence
whether or not surgery will be more effective than non-surgical alternatives. For example, the
age of a patient and the number of comorbidities may well influence which mode of treatment
should be preferred. We next explore how accounting for additional heterogeneity in the matched
pair outcomes that is predictable on the basis of effect modifiers may further decrease reported
sensitivity to hidden bias. After doing so, we present theoretical results to help explain the pattern
in Table 3 of smaller treatment effects being considerably less sensitive to hidden bias.
5. Improved standard errors for sensitivity analysis by exploiting effect
modification
5.1. Conservativeness of finite population sensitivity analysis under effect heterogene-
ity. Proposition 1 tells us that rejecting the null hypothesis H
(λ0)
weak through the test ϕ
(λ0)(α,Γ)
provides an asymptotically valid sensitivity analysis, in the sense that if (1) holds at Γ then the
test will commit a Type I error with probability at most α in the limit. In practice, however, it may
well be the case that ϕ(λ0)(α,Γ) << α under H
(λ0)
weak, resulting in a conservative testing procedure.
To see why, imagine that we had access to E(L¯Γ | F ,Z) and sd(L¯Γ | F ,Z), the true expectation
and standard deviation of the conditional distribution L¯Γ | F ,Z. In this case, rejecting the null
hypothesis when the test statistic {L¯Γ − E(L¯Γ | F ,Z)}/sd(L¯Γ | F ,Z) exceeds Φ−1(1 − α) would,
under mild conditions ensuring that a central limit theorem holds for L¯Γ, result in a test statistic
with asymptotic level exactly equal to α. Unfortunately, this test statistic cannot be deployed in
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practice. For Γ > 1 the expectation E(L¯Γ | F ,Z) cannot be computed due to its dependence on
both the vector of unmeasured confounders u and the missing potential outcomes, which are not
imputed under the weak null H
(λ0)
weak. Further, for any value of Γ, sd(L¯Γ | F ,Z) is also unknown when
effects are heterogeneous. By using the test statistic L¯Γ/se(L¯Γ), our procedure overcomes these
difficulties by means of the bounds E(L¯Γ | F ,Z) ≤ 0 and (2) var(L¯Γ | F ,Z) ≤ E{se(L¯Γ)2 | F ,Z}.
See Lemmas 2 and 3 of Fogarty (2019) for proofs of these inequalities.
That E(L¯Γ | F ,Z) is unknown under H(λ0)weak is a feature unique to a sensitivity analysis when
Γ > 1. In a randomized encouragement design (Γ = 1), it is known that E(L¯Γ | F ,Z) = 0 under
the null even if effects are heterogeneous. For continuous outcomes, the bound E(L¯Γ | F ,Z) ≤ 0
is sharp for Γ > 1, in that the upper bound is actually attained at the worst-case distribution for
L¯Γ under the proportional dose model. For this reason, using an expectation smaller than zero
when performing a sensitivity analysis is not justified without additional assumptions about the
treatment effects and the pattern of hidden bias. While we cannot generally hope to improve upon
the bound E(L¯Γ | F ,Z) ≤ 0 without risking an anti-conservative procedure, we now illustrate
that improvements on se(L¯Γ) can be attained while preserving the asymptotic level of the resulting
sensitivity analysis.
5.2. A general construction of valid standard errors for sensitivity analysis. Extending
Lemma 3 of Fogarty (2019) to encouragement designs, we have
E{se(L¯Γ)2 | F ,Z} = var(L¯Γ | F ,Z) + 1
n(n− 1)
n∑
i=1
(µΓi − µ¯Γ)2,
where µΓi = E(LΓi | F ,Z) is the true, but unknowable, expectation of LΓi and µ¯Γ = n−1
∑n
i=1 µΓi.
The bias in se(L¯Γ) thus depends upon the degree of heterogeneity in the expectations µΓi. We
can interpret the magnitude of the bias as the mean squared error estimate from a regression of
µΓi on an intercept column 1n, a vector containing n ones. Imagine now that, based on covariate
information at our disposal, we were able to account for some of the variation in µΓi through
covariance adjustment. This would reduce the mean squared error, and hence the degree of bias.
We now present a general construction for standard error estimators that make use of this idea,
resulting in less conservative estimate of se(L¯Γ) while nonetheless providing an asymptotically valid
sensitivity analysis for any value of Γ.
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Let Q be an n×p matrix with p < n that is constant across all z ∈ Ω, and let H = Q(QTQ)−1QT
be the orthogonal projection of Rn onto the column space of Q. Let hik be the {i, k} element of H
and let L˜Γi = LΓi/
√
1− hii. Define the new variance estimator se(L¯Γ; Q)2 as
se(L¯Γ; Q)
2 =
1
n2
L˜TΓ(I−H)L˜Γ, (4)
where I is the n× n identity matrix and L˜Γ = (L˜Γ1, . . . , L˜Γn)T .
Proposition 3. For any value of Γ,
E{se(L¯Γ; Q)2 | F ,Z} − var(L¯Γ | F ,Z) = 1
n2
µ˜TΓ(I−H)µ˜Γ ≥ 0.
where µ˜Γ = (µ˜Γ1, . . . , µ˜Γn)
T , and µ˜Γi = µΓi/
√
1− hii.
The proof of Proposition 3 follows that of Proposition 1 in Fogarty (2018). The result states
that regardless of the true value of Γ for which (1) holds and regardless of the form for the matrix
Q, se(L¯Γ,Q)
2 will be conservative in expectation for var(L¯Γ | F ,Z) so long as Q does not vary
across Ω.
5.3. A regression-based standard error. Setting Q = 1n recovers the usual standard error
estimator, i.e, se(L¯Γ,1n) = se(L¯Γ) as defined in §4.1. Guided by the form of the bias, we see
that Q should be chosen to predict the individual-level expectations µ˜Γi ≈ µΓi. One choice would
be to let Q = (1, X¯) be a n × (k + 1) matrix where the qth column of X¯ is (x¯1q, . . . , x¯nq)T ,
and where x¯iq = (xi1q + xi2q)/2, the average of the qth covariate’s values in the ith pair. The
ith row of X¯ then contains the average of the k covariates within pair i, reflecting a hope that
the heterogeneous expectations µΓi may be linear in the within-pair covariate averages. Under
mild regularity conditions, it can be shown that the modified variance estimator se(L¯Γ; Qreg) with
Qreg = (1n, X¯) is asymptotically never worse than se(L¯Γ), regardless of whether or not µΓ is truly
linear in the within-pair covariate averages X¯.
Proposition 4. Take Qreg = (1n, X¯). If µΓ is not a constant vector, then under regularity
conditions,
se(L¯Γ; Qreg)
2 − var(L¯Γ | F ,Z)
se(L¯Γ; 1n)2 − var(L¯Γ | F ,Z)
p−→ 1−R2,
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where R2 is the coefficient of determination from a regression of µΓ on (1n, X¯). If µΓ is a constant
vector, then se(L¯Γ; 1n)
2/var(L¯Γ | F ,Z) p→ 1 and se(L¯Γ; Qreg)2/var(L¯Γ | F ,Z) p→ 1.
Sufficient conditions for Proposition 4 are presented along with its proof in the supplementary
materials. Under the same conditions, the conclusion of Proposition 4 would hold replacing L˜Γ
with LΓ, and with 1/n
2 replaced by 1/{n(n− k − 1)} in (4). In that case, the resulting standard
error estimator would simply be the RMSE from a regression of LΓ on (1n, X¯), divided by
√
n.
5.4. A nonparametric approach: pairing the pairs through nonbipartite matching.
While the regression-based standard error does not re quire a properly specified linear model for its
validity, the gains are dependent on the extent to which µΓ is linear in Q. While averages of poly-
nomial terms can be included within X¯, alternative nonparametric approaches may be preferred.
Here we illustrate that a variant of the approach first considered in Abadie and Imbens (2008) can
also be employed in a finite population sensitivity analysis.
Suppose that n is even for simplicity, and consider “pairing the pairs” through the use of optimal
nonbipartite matching based on Mahalanobis distances between the average values of the within-
pair covariates x¯i. This results in n/2 “pairs of pairs,” where matched pairs have been matched to
other matched pairs with similar average values for x¯i. For each pair i, let J (i) be the index of the
pair that was matched with the ith pair such that J (J (i)) = i. Consider the variance estimator
se(L¯Γ; QPoP )
2 =
1
2n2
n∑
i=1
(LΓi − LΓJ (i))2, (5)
which simply squares the differences in the terms LΓi within each pair of pairs
Proposition 5.
E{se(L¯Γ; QPoP )2 | F ,Z} − var(L¯Γ | F ,Z) = 1
2n2
n∑
i=1
(µΓi − µΓJ (i))2.
While a proof unique to this estimator follows by expanding the square, the result can also be
obtained through Proposition 3. Let QPoP be the n× (n/2) matrix with the qth column containing
membership indicators for the qth of n/2 pairs of pairs. This design matrix yields hii = 1/2, such
that L˜Γi =
√
2LΓi. Observe that as the average values x¯i are fixed over z ∈ Ω, the pairing of pairs
encoded within QPoP is also constant over the randomization distribution. The residual vector
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(I − HPoP )L˜Γ has
√
1/2(LΓi − LΓJ (i)), in its ith entry, and the analogous form holds for the
residual vector (I −HPoP )µ˜Γ. Summing the squares of these residuals and dividing by n2 shows
that Proposition 3 recovers both the estimator and the correct bias formula.
An odd number of pairs can readily be accommodated through a host of corrections. One
approach is inspired by the output of the nonbimatch function within the nbpMatching package in
R (Lu et al. 2011), a common package for nonbipartite matching. When given an odd number of
elements, nonbimatch introduces a “ghost” element has zero distance between all other elements,
and then proceeds with the optimization problem. The pair matched to the ghost is, in reality,
not matched to any other pair. We can then match the unmatched pair to the most similar pair
of pairs, creating (n− 1)/2− 1 pairs of pairs and one triple of pairs. One could then proceed with
QPoP as the n× (n−1)/2 matrix, where the first (n−1)/2−1 columns contain indicators for pairs
of pairs membership, and the final column contains binary indicators for membership in the lone
triple. By Proposition 3, the estimator se(L¯Γ; QPoP )
2 is a conservative estimate for var(L¯Γ | F ,Z).
5.5. Comparative improvement and fundamental limitations of bias reduction for finite-
population standard errors. Abadie and Imbens (2008) consider a superpopulation formulation
wherein the covariates x are viewed as fixed, but the potential outcomes are random. Under this
generative framework, they show that under suitable regularity conditions, n × se(L¯1; QPoP )2 is
consistent for n×var(L¯1 | x,Z) in randomized experiments with perfect compliance. Note however
that even at Γ = 1, the target of estimation in our framework is instead var(L¯1 | F ,Z), and that
F includes the potential outcomes. That inference conditions upon the potential outcomes results
in what Ding et al. (2019) refer to as an idiosyncratic component of heterogeneity which cannot be
explained by observed covariates. As a result, n × se(L¯Γ; QPoP )2 will not generally be consistent
for n× var(L¯Γ | F ,Z). Instead, it will have a positive asymptotic bias determined by the limiting
value of (2n)−1
∑n
i=1(µΓi − µΓJ (i))2 given F and Z, which generally cannot be driven to zero as
it depends on idiosyncratic features of the observed study population. Nonetheless, by pairing
the pairs one may reasonably expect that the explainable portion of the variation in µΓi has been
captured in the limit so long as the underlying function is sufficiently well-behaved, whereas the
method based on linear regression may fail to entirely do so under misspecification.
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To develop intuition, imagine for a moment that the terms µΓi = E(L¯Γi | F ,Z) are themselves
drawn from a distribution conditional upon xi with expectation η(xi) and variance σ
2(xi). Let
ε(xi) = µΓi − η(xi) such that E{ε(xi) | xi} = 0. Under suitable regularity conditions, the limiting
bias in n× se(L¯Γ; Qreg)2 as an estimator of n× var(L¯Γ | F ,Z) is
n{se(L¯Γ; Qreg)2 − var(L¯Γ | F ,Z)} p→ lim
n→∞n
−1{η(x) + ε(x)}T (I−Hreg){η(x) + ε(x)}
= n−1 lim
n→∞η(x)
T (I−Hreg)η(x) + n−1 lim
n→∞
n∑
i=1
ε2(xi).
The term n−1 lim
n→∞
∑n
i=1 ε
2(xi) in the expression is the idiosyncratic effect variation described in
Ding et al. (2019), and appears because inference is being conducted conditional upon F with the
potential outcomes fixed, rather than conditional upon only xi while viewing the potential outcomes
as random. The bias would only depend upon this idiosyncratic term were η(xi) linear in xi, but
an additional positive factor persists under misspecification. For the pairs of pairs estimator, under
suitable moment conditions given in Abadie and Imbens (2008), we instead have
n{se(L¯Γ; QPoP )2 − var(L¯Γ | F ,Z)} p→ lim
n→∞(2n
−1)
n∑
i=1
{η(xi)− η(xJ (i)) + ε(xi)− ε(xJ (i))}2
= lim
n→∞(2n
−1)
n∑
i=1
{η(xi)− η(xJ (i))}2 + n−1 lim
n→∞
n∑
i=1
ε2(xi),
Under additional Lipschitz and boundedness conditions on η(xi) along with an assumption that
n−1
∑n
i=1 ||xi−xJ (i)||2 tends to zero, arguments akin to those in Abadie and Imbens (2008) imply
that lim
n→∞(2n)
−1∑n
i=1{η(xi) − η(xJ (i))}2 = 0. Under these conditions, it would then follow that
plim
n→∞
se(L¯Γ; QPoP )/se(L¯Γ; Qreg) ≤ 1, such that se(L¯Γ; QPoP ) would provide a less conservative
standard error in the limit than se(L¯Γ; Qreg).
6. Improved sensitivity analysis and an omnibus test
6.1. An improved sensitivity analysis for sample average effects. The standard errors in
§5 can be used to improve the power of the sensitivity analysis for IV while maintaining the
asymptotic level of the test. Consider conducting a sensitivity analysis at Γ using L¯Γ/se(L¯Γ; Q)
as a test statistic for some matrix Q instead of L¯Γ/se(L¯Γ). Let GΓ(·; Q) be the distribution of
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B¯Γ/se(B¯Γ; Q) given |ζ(λ0)|, where B¯Γ is defined as in §4.1. The modified test is
ϕ
(λ0)
Q (α,Γ) = 1{L¯Γ/se(L¯Γ; Q) ≥ G−1Γ (1− α; Q)}.
Proposition 6. Suppose (1) holds at Γ and that H
(λ0)
weak is true. Then, under regularity conditions,
lim
n→∞E{ϕ
(λ0)
Q (α,Γ)} ≤ α,
such that the procedure yields a valid level−α sensitivity analysis for the effect ratio with heteroge-
neous effects. Furthermore, for Q = Qreg or Q = QPoP and regardless of whether or not the null
holds, then under regularity conditions
lim
n→∞E{ϕ
(λ0)
Q (α,Γ)} ≥ limn→∞E{ϕ
(λ0)(α,Γ)},
such that the new procedure is both less conservative under the null and more powerful under the
alternative than the procedure employing the conventional standard error estimator.
We leave a sketch of the proof along with a discussion of sufficient conditions for the appendix,
but intuition can be formed from the discussion in the previous section. The magnitude of the
improvement will depend upon the extent to which se(L¯Γ; Q) improves upon the conventional
standard error estimator, se(L¯Γ). In understanding the differences between ϕ
(λ0)
Q and ϕ
(λ0), it is
useful to consider how one would use Monte-Carlo simulation to approximate the test. Algorithm
1 contains the required steps for any matrix Q, and Q = 1n returns the test in (3) with the
conventional standard error.
6.2. Understanding performance in a simulation study. We now conduct a simulation study
to further illustrate the potential improvements that standard errors exploiting effect modification
may provide. In each simulated data set there are n pairs, each matched exactly on a k ≥ 5
dimensional vector of covariates xi. In the mth of M iterations, the pair-specific covariate vector
is drawn such that each component is iid Uniform on the interval [0,1]. The treatments actually
received dij(z) (z = 0, 1) are binary. We assume that there are no defiers, that the exclusion
restriction holds, and that individuals ij are assigned status as compliers (dij(1) = 1, dij(0) = 0),
never-takers (dij(1) = dij(0) = 0), and always-takers (dij(1) = dij(0) = 1) independently with
probability pC = 0.75, pN = 0.125, and pC = 0.125 respectively. We then use the functional form
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Algorithm 1 Studentized sensitivity analysis at Γ with improved standard errors
(1) Form a matrix Q and its hat matrix H = Q(QTQ)−1QT
(2) In the mth of M iterations:
(a) Generate VΓi
iid∼ 2×Bernoulli
(
Γ
1+Γ
)
− 1 for each i.
(b) Compute BΓi = VΓi|ζ(λ0)i | −
(
Γ−1
1+Γ
)
|ζ(λ0)i | for each i.
(c) Compute B¯Γ = n
−1∑n
i=1BΓi.
(d) Form B˜Γi = BΓi/
√
1− hii for each i
(e) Compute se(B¯Γ; Q) as
se(B¯Γ; Q) =
√
1
n2
B˜TΓ(I−H)B˜Γ.
(f) Compute A
(m)
Γ = B¯Γ/se(B¯Γ; Q); store this value across iterations.
(3) Approximate the bound on the greater-than p-value by
pˆval =
1 +
∑M
m=1 1{A(m)Γ ≥ L¯obsΓ /se(L¯obsΓ ; Q)}
1 +M
for the potential outcomes suggested in Fogarty (2018, §7.1), suitably modified to include potential
noncompliance. For z = 0, 1,
yij(z) =

a
(
10 sin(pixi1xi2) + 20(xi3 − 1/2)2 + 10 exp(xi4) + 5(xi5 − 1/2)3 + εij
)
dij(z) = 1
10 sin(pixi1xi2) + 20(xi3 − 1/2)2 + 10 exp(xi4) + 5(xi5 − 1/2)3 + εij dij(z) = 0
εij
iid∼ N (0, 1).
We proceed with two different values of a in the above model: a = 1 and a = 2. At a = 1 the
proportional dose model described in §3.2 holds at λ = 0, and there is no effect modification. At
a = 2 effect modification is present and is nonlinear in the observed covariates.
The effect ratio in simulation m is λm, and is determined once the potential outcomes and dosages
received are simulated. We imagine that there is no hidden bias, such that (1) holds at Γ = 1. We
then proceed with inference for the null hypothesis λ = λm at Γ = 1 with a two-sided alternative,
and we set α = 0.1. As H
(λm)
weak is true and that the sensitivity model holds at Γ = 1, our proposed
methods for sensitivity analysis using ϕ
(λm)
Q (0.1, 1) should commit a Type I error with probability
at most 0.1. We compare three choices for the matrix Q used to form the variance estimator in (4):
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(1) Intercept. Including only the intercept column, recovering the usual variance estimator for
a paired design.
(2) Linear. Including a constant column and the covariates xi.
(3) Pairs of Pairs. Form pairs of pairs with similar covariate values through nonbipartite
matching as described in §5.4, and estimate the variance by (5).
In each iteration we also construct 90% confidence intervals at Γ = 1 for λm through inverting
the test ϕ
(λ0)
Q , and compare the widths of the intervals generated by the three choices for Q. In
addition to varying the value of a, we also vary the sample size between n = 100 and n = 2500,
and the number of covariates between k = 5 and k = 10. Observe that the potential outcomes
depend only on the first five covariates, such that the setting with k = 10 includes five irrelevant
covariates.
Table 4. Simulated performance of our testing procedure with different standard
error estimators. The desired Type I error rate in all settings is α = 0.1.
Standard Error Estimator
Intercept Linear Pairs of Pairs
Size CI Length Size CI Length Size CI Length
Prop. Dose n = 100 k = 5 0.101 0.636 0.101 0.636 0.102 0.640
Prop. Dose n = 100 k = 10 0.099 0.637 0.099 0.637 0.101 0.641
Prop. Dose n = 2500 k = 5 0.101 0.125 0.098 0.125 0.100 0.125
Prop. Dose n = 2500 k = 10 0.102 0.125 0.097 0.125 0.105 0.125
Effect Mod. n = 100 k = 5 0.002 2.648 0.027 1.848 0.024 1.927
Effect Mod. n = 100 k = 10 0.003 2.646 0.028 1.845 0.012 2.135
Effect Mod. n = 2500 k = 5 0.002 0.514 0.026 0.364 0.044 0.337
Effect Mod. n = 2500 k = 10 0.002 0.514 0.029 0.363 0.025 0.372
Table 4 contains the results from the simulation study. We first observe that under the propor-
tional dose model, the estimated size for all three procedures was roughly 0.1 for each combination
of covariate dimension and sample size. This should not come as surprise, as under the proportional
dose model all three procedures are guaranteed to be finite-sample exact since they are random-
ization tests; discrepancies from 0.1 in the table are the result of simulation error. The confidence
interval lengths are also comparable within each combination of k and n since all three standard
errors times
√
n are consistent for
√
n× sd(L¯Γ | F ,Z) under proportional doses.
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When effect modification is present, we observe that in all simulations the true Type I error
rates from the resulting methods fall well below the desired size. While the covariates xi are effect
modifiers, the simulation study contains idiosyncratic, irreducible effect heterogeneity in the form
of the εij terms. As described in §5.5, this induces conservativeness in the resulting inference.
We see that by using covariate information the regression-based and pairs of pairs standard errors
both outperform the conventional standard errors, which results in less conservative inference and
narrower confidence intervals. Despite the fact that the effect modification is nonlinear in the
observed covariates, the regression-based standard error outperforms the pairs of pairs procedure
in every simulation setting except for (n = 2500, k = 5). This is due to the difficulties faced by
nonparametric estimation in low sample, high covariate dimension regimes. Note that this does
not corrupt the procedure based on the pairs of pairs standard error in terms of invalid inference,
but it does limit its efficacy. This reflects the bias-variance tradeoff: in small samples and/or with
a large number of covariates, it may be the case that a misspecified linear model produces better
results than the nonparametric pairs of pairs approach due to improved stability of the estimated
functional form.
6.3. An omnibus test for effect heterogeneity in instrumental variable studies. Fogarty
(2018, §6) describes how the discrepancy between standard errors involving covariate information
and the conventional standard error estimator for a paired design can be used to form an exact test
for the null hypothesis of no effect modification. In the context of an instrumental variable design,
this amounts to a test of the null hypothesis that the proportional dose model holds for some λ0,
H0 : yij(1)− yij(0) = λ0{dij(1)− dij(0)} for all i, j, for some λ0, (6)
against the alternative that it does not hold for all i, j and for any shared value of λ0.
Suppose that Γ = 1, and for a given value λ0 consider as a test statistic the F -statistic comparing
a regression of ζ
(λ0)
i on (a) a design matrix incorporating covariates, such as Qreg or QPoP ; to (b)
the null model containing only an intercept column. If effect modification existed on the basis of
the observed covariates, one would expect the regression incorporating covariates to reduce the
sum of squared error relative to a model containing only an intercept, which would in turn inflate
the F -statistic. Call the resulting statistic F (Z, ζ(λ0)). If the proportional dose model holds at λ0,
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then |ζ(λ0)i | would be fixed across randomizations with only its sign varying. This would allow for
computation of a randomization-based p-value for the proportional dose model holding at λ0:
p(λ0) =
1
2n
∑
z∈Ω
1{F (z, ζ(λ0)) ≥ f (λ0)}, (7)
where f (λ0) is the observed value of the test statistic.
The value of λ0 is a nuisance parameter for testing (6). Under perfect compliance, i.e. the typical
paired experiment, Proposition 3 of Fogarty (2018) shows that F (Z, ζ(λ0)) is pivotal with respect to
the particular value of λ0, such all values for λ0 yield the same p-value, and any value for λ0 could
be used to test (6). Unfortunately, this does not hold in the presence of noncompliance, meaning
that p(λ0) varies as a function of λ0. To overcome this, we employ the approach of Berger and Boos
(1994) to create a test of the hypothesis in (6). By the lemma of Berger and Boos (1994, §2), a
valid p-value for (6) is
pβ = sup
λ0∈CI1−β
p(λ0) + β. (8)
where CI1−β is any 100(1−β)% confidence interval for λ0 under the assumption of the proportional
dose model. This permits the use of randomization-based confidence intervals derived in Imbens
and Rosenbaum (2005) and Rosenbaum (2002b, §5.4) formed using test statistics other than the
difference in means. However, for the purposes of improving the power of the test when effect
modification is present, the confidence intervals described in §6.1 based on improved standard
errors may be preferred. Through employing a randomization distribution, the resulting procedure
yields an exact test of (6) for any sample size. See Ding et al. (2016) for other examples of
randomization-based tests of treatment effect heterogeneity.
An omnibus test of effect heterogeneity is of special interest for instrumental variable studies.
Even if one assumes monotonicity and the exclusion restriction, the effect ratio merely attests to
the sample average treatment effect among compliers, rather than the average treatment effect for
the study population. Some authors argue that a key weakness of IV designs is that they only
identify this more local estimand (Deaton 2010; Swanson and Herna´n 2014, 2017). For an IV
design to provide an estimate of the SATE, the investigator must invoke an effect homogeneity or
no-interaction assumption (Robins 1994; Herna´n and Robins 2006). If we fail to reject the null
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hypothesis in (6), there is no evidence to reject the proportional dose model or to suggest that
effect heterogeneity is present. If effects are roughly homogeneous, the IV estimand may be a good
proxy for the sample average treatment effect in the study population.
6.4. Application to the EGS study. Table 5 contains a comparison of 95% confidence intervals
calculated at Γ = 1 and sensitivity values within the septic and non-septic subgroups for the
hospital length of stay outcome using three standard errors: the conventional standard error for
a paired design, the regression-based standard error, and one formed by pairing together pairs on
the basis of observed covariates. In our application, the different standard error estimators did not
materially alter the confidence interval lengths. We found that the Γ changepoints were also similar
across standard errors. Results for the complication and mortality outcomes indicated a similar
trend and are omitted here.
Table 5. Confidence intervals and sensitivity values for hospital length of stay with
different standard errors.
Septic Patients
Standard Error 95% Conf. Int. Sensitivity Value
Conventional [ 3.87 , 8.71 ] 1.64
Regression-based [ 4.03 , 8.69 ] 1.62
Pair of Pairs [ 4.01 , 8.66 ] 1.64
Non-septic Patients
Standard Error 95% Conf. Int. Sensitivity Value
Conventional [ 3.36 , 4.81 ] 2.36
Regression-based [ 3.36 , 4.81 ] 2.38
Pair of Pairs [ 3.37 , 4.82 ] 2.37
This lack of improvement suggests that there is little evidence for substantive effect modification
within the sepsis and non-sepsis subgroups on the basis of other patient characteristics. To formally
test this, we use the test of the proportional dose model described in §6.3. We set β = 0.01, and
construct a 99% confidence interval for λ0 by inverting the test ϕ
(λ0)
QPoP
at Γ = 1. We then maximize
(7) over λ0 in this confidence interval, and form p0.01 through (8). For septic patients, the resulting
p-value for the complication outcome is 0.65, and the p-value is 0.10 for the length of stay outcome.
Within the non-septic patients, the p-values are 0.67 and 0.77 for the complication and length of
stay outcomes respectively. Therefore, we fail to reject the null hypothesis that the proportional
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dose model holds in both subgroups, finding little evidence that the IV estimates vary as a function
of over 90 additional observed covariates.
7. Heterogeneity and design sensitivity in IV studies
7.1. Larger but brittler effect estimates. While there was no evidence for effect modification
within the septic and non-septic subgroups on the basis of observed covariates, the effect ratio
estimates within the septic group were larger than those in the non-septic subgroup for all three
outcomes as presented in Table 2. As Table 3 illustrates, the results from the sensitivity analysis
are reversed for length of stay and complication. For the complication outcome, we were able
to reject the null of no effect ratio until Γ = 1.56 and Γ = 1.59 for the septic and non-septic
groups respectively. For the length of stay variable, the discrepancy is even more substantial: for
two individuals in the same matched set, a hidden variable would need to produce discrepancies
in the odds that the individuals were assigned to a surgeon with a higher TTO by a factor of
1.64 in the septic group to explain away the finding of no effect ratio, while in the septic-group
the odds would need to differ by a factor 2.36. Despite the septic subgroup having the larger
estimated effects, the estimates for the non-septic group proved to be more robust to hidden bias.
We now demonstrate how this phenomenon is reflective of the importance of reduced within-pair
homogeneity for reducing sensitivity to hidden bias.
7.2. A favorable reality unknown to the practitioner. Imagine that Zij were actually a valid
instrument and that, furthermore, the true value for the effect ratio exceeded its hypothesized value.
Given that our instrument is not randomly assigned, a critic could always counter that a large effect
estimate may be attributable not to a treatment effect, but rather to bias from lurking variables
invalidating the proposed instrument. Even in this favorable situation of a valid instrument and
a positive treatment effect, we would hope that our inferences would prove robust to moderate
degrees of hidden bias to protect ourselves against such criticism. Theoretical calculations within
this section proceed under this favorable setting: there is truly no hidden bias, there is truly an
effect, but the practitioner is blind to this fact and hence hopes that her inferences perform well
under the stress of a sensitivity analysis. In this way, we assess our method’s ability to discriminate
between (1) no treatment effect and hidden bias; and (2) a treatment effect without hidden bias.
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Until this point inference has been performed conditional upon F , and a generative model for
F has been neither required nor assumed. For the calculations in this section, it is convenient to
assume a superpopulation model. Because F will be viewed as random, the procedures exploiting
effect modification presented in §6.1 no longer provide valid tests for the effect ratio; see Foga-
rty (2018, §5) for more on the relationship between superpopulation formulations and validity of
standard errors using covariate information. We thus focus attention in the sensitivity analysis
given in (3) using the conventional standard error estimate, ϕ(λ0), which remains valid under the
superpopulation setting considered here. Following Small and Rosenbaum (2008), we imagine that
ζ
(λ0)
i is generated as
ζ
(λ0)
i = i + Si(λ− λ0), (9)
where i = (Zi1 − Zi2){(Yi1 − Yi2) − λ(Di1 − Di2)} are the encouraged-minus-non encouraged
differences in responses adjusted according to the treatment actually taken, and Si = (Zi1 −
Zi2)(Di1 − Di2) are the encouraged-minus-non encouraged differences in the treatment received,
reflecting the strength of the instrument. Note that this generative model does not imply the
proportional dose model, such that the individual-level effects are allowed to be heterogeneous.
We assume that i are iid from a symmetric distribution with mean zero and finite variance σ
2.
The treatments actually received are assumed binary. We assume that there are no defiers, that the
exclusion restriction holds, and that individuals ij are assigned status as compliers, never-takers
and always-takers independently with probability pC , pN , and pA respectively. This results in
pr(Si = 1) = pC + pApN , pr(Si = −1) = pApN and pr(Si = 0) = 1− pC − 2pApN . The terms ζ(λ0)i
are iid draws from a mixture distribution with three components, namely
ζ
(λ0)
i =

i + (λ− λ0) w.p. pC + pApN
i w.p. 1− pC − 2pApN
i − (λ− λ0) w.p. pApN .
(10)
The parameter λ represents the true treatment effect among compliers, while λ0 is its value under
the null.
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7.3. Design sensitivity. In a sensitivity analysis, bias dominates variance in large samples. In
fact, under mild regularity conditions there is a number Γ˜, called the design sensitivity, such that
the power of a sensitivity analysis tends to 1 if Γ < Γ˜ and tends to 0 if Γ > Γ˜ as n → ∞ in the
favorable situation of no bias in treatment assignment (Rosenbaum 2004). The design sensitivity
can be used as a means of appraising competing design strategies, comparing different test statistics,
and assessing the impact of different assumptions within a sensitivity analysis. Larger values for Γ˜
indicate reduced sensitivity of inferences to unmeasured confounding in large samples.
For any value of Γ, our procedure employs the random variable L¯Γ = n
−1∑n
i=1{ζ(λ0)i −(Γ−1)/(1+
Γ)|ζ(λ0)i |}. Under the favorable situation being considered this random variable has expectation
E(ζ
(λ0)
i )− (Γ− 1)/(1 + Γ)E|ζ(λ0)i |, where
E(ζ
(λ0)
i ) = pC(λ− λ0), (11)
E|ζ(λ0)i | = (pC + 2pApN )E|i + (λ− λ0)|+ (1− pC − 2pApN )E|i|
are expectations with respect to the mixture distribution (10). The second line uses symmetry of
i about zero. In a sensitivity analysis, we replace this true expectation with 0, the worst-case
expectation for L¯Γ under the null hypothesis. Under mild conditions, the design sensitivity is
simply the value of Γ that solves E(ζ
(λ0)
i )− (Γ− 1)/(1 + Γ)E|ζ(λ0)i | = 0.
Proposition 7. Suppose that the paired differences ζ
(λ0)
i are drawn iid from the mixture distribution
(12), and that i are drawn iid from a symmetric, mean zero distribution with finite variance. Then,
the design sensitivity is
Γ˜ =
E|ζ(λ0)i |+ E(ζ(λ0)i )
E|ζ(λ0)i | − E(ζ(λ0)i )
. (12)
Proof. Under iid draws from a distribution with finite variance the strong law of large numbers
applies to n × se(L¯Γ)2. Therefore, Proposition 2 of Rosenbaum (2013) holds, and Corollary 1 of
Rosenbaum (2013) yields the formula for the design sensitivity. 
Remark 3. Despite not resulting in a valid level−α sensitivity analysis in the superpopulation
setting considered here, an analogous proof shows that ϕ
(λ0)
Q also has the design sensitivity given in
(12). This is yet another reflection of bias trumping variance in observational studies considering
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hidden bias. In the limit, sensitivity to hidden bias is determined by the extent to which a test
statistic can control the worst-case bias at Γ, and discrepancies in variance become irrelevant. So
while exploiting effect modification can provide improvements in power under the assumption of
no hidden bias even in the limit for finite-population causal inference, there is a sense in which
improvements provided by exploiting effect modification for the changepoint value for Γ reported
by a sensitivity analysis are confined to small and moderate sample sizes.
Remark 4. The formula for the design sensitivity would remain unchanged had we used the test
statistic L¯Γ instead of the studentized statistic L¯Γ/se(L¯Γ). The sensitivity analysis based on the
unstudentized L¯Γ is common in practice and is called the permutational t-test (Rosenbaum 2007),
applied here to the adjusted paired differences (Zi1 − Zi2){(Yi1 − Yi2) − λ0(Di1 − Di2)}. The
studentization is essential for maintaining the correct Type I error rate in the presence of heteroge-
neous effects (Fogarty 2019, Theorem 4), and through Proposition 7 we see that it does so without
sacrificing performance relative to the non-studentized L¯Γ in the favorable setting of no bias.
7.4. Making sense of our sensitivity analysis. The formula for design sensitivity in (12)
demonstrates the dependence of a sensitivity analysis’s limiting power on various components of
the data generating process. While the magnitude of the effect relative to its postulated value
matters, so too does the proportion of compliers relative to always-takers and never-takers. The
variance of i, reflecting the degree of within-pair heterogeneity, plays an important role through
its influence on E|i| and E|i + λ − λ0|. These results help explain the phenomenon observed in
our data, where larger treatment effect estimates in the septic subgroup were less robust to hidden
bias than the smaller estimates in the non-septic subgroup.
Consider the length of stay outcome variable, and suppose for the purpose of illustration that the
estimated effect ratios are actually the true values of λ, such that λS = 6.8 for septic patients and
λNS = 4.1 for the non-septic patients. Suppose further that the standard deviation of ζ
(λS)
i and
ζ
(λNS)
i in our sample reflect the true standard deviations for the distribution of i in the septic and
non-septic subgroups, yielding σS = 25.3 and σNS = 8.9. Table 6 gives the design sensitivities from
(12) using these values for λ and σ assuming both Normal and Laplace distributions for i, and
varying the proportion of compliers. First, the role of instrument strength is pivotal for the design
sensitivity of an instrumental variable study. In keeping with Small and Rosenbaum (2008), we
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observed that the weaker the instrument, the lower the design sensitivity becomes, and results from
IV studies with weak instruments are generally highly sensitive to hidden bias. Furthermore, we see
that for a given level of compliance and regardless of distribution, the parameter settings motivated
by the non-septic subgroup, with a lower effect ratio but lower heterogeneity, outperforms the septic
subgroup in terms of design sensitivity. This illustrates that in the limit, a smaller treatment effect
may well prove more robust to hidden bias when the data exhibit lower heterogeneity.
Table 6. Design sensitivity calculations with parameters inspired by septic and
non-septic length of stay effect estimates, varing the percentage of compliers and
the distribution for i in (9). Calculations assume there are no defiers, and that
noncompliers are equally likely to be always-takers and never-takers.
Normal Laplace
Compliance 100% 75% 50% 25% 10% 100% 75% 50% 25% 10%
Septic
1.97 1.65 1.39 1.18 1.07 2.11 1.75 1.45 1.20 1.08
λ = 6.8; σ = 25.3
Non-septic
3.19 2.33 1.74 1.32 1.12 3.50 2.51 1.83 1.35 1.13
λ = 4.1; σ = 8.9
In small and moderate samples, discrepancies in the standard errors of test statistics play a larger
role in the power of a sensitivity analysis. Using a simulation study, we now compare the role that
the effect size relative to both the standard error and to individual-level variability plays in an
observational study. To do so, we maintain the parameter values from the septic and non-septic
groups and fix a common percentage of compliers, always-takers, and never-takers, but simulate
from the generative model (9) using different sample sizes for the septic and non-septic groups.
The ratio of the variances of i in the septic and non-septic subgroups is σ
2
S/σ
2
NS ≈ 8, and we
set nS/nNS , the ratio of the sample sizes for the septic and non-septic groups, to also equal 8.
We do this so that the variances of the sample averages of the i terms in both groups, σ
2
S/nS
and σ2NS/nNS , are approximately equal. The equality of these variances for the sample mean may
appear to put inference within the non-septic subgroup at a disadvantage: as λS > λNS , inference
at Γ = 1 for the null of no effect ratio would be more powerful in the septic group than in the
non-septic group. Does this disadvantage carry over to a sensitivity analysis at Γ > 1?
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In each simulation, nS and nNS observations are drawn from the mixture distribution in (12),
with parameters (λS , σ
2
S) and (λNS , σ
2
NS) and with i normally distributed. We assume there are
no defiers, set the probability of compliance to pC = 0.75, and set pA = pN = (1 − pC)/2 for
always-takers and never-takers. After drawing the samples, we conduct a sensitivity analysis at
Γ, and record whether or not we correctly reject the null of zero effect ratio for each subgroup.
We conduct this simulation study for nS = 200, 1000, 2000, 10, 000, with corresponding values
nNS = 25, 125, 250, 1250, and over a range of values for Γ. For each combination of sample sizes
and values of Γ, we run 10,000 simulations. Through this simulation, we highlight the different roles
that sample size can play for inference both assuming no hidden bias (Γ = 1) and in a sensitivity
analysis.
Figure 1 presents the results of the simulation study. Each plot shows the performance of the
sensitivity analyses in the septic and non-septic subgroups, varying nS while maintaining nS/nNS =
8. For instance, the upper-left panel shows the performance in a sensitivity analysis as a function of
Γ with nS = 200, and nNS = 25. Assuming no hidden bias (Γ = 1), the test in the septic subgroup
has higher power as λS > λNS and σ
2
NS/nNS ≈ σ2S/nS . As Γ increases, we see that despite the
smaller effect size the test in the non-septic subgroup begins to outperform that in the septic group,
owing to the fact that σ2NS < σ
2
S . As nS increases with nS/nNS fixed, we see that the larger sample
size in the septic-group provides a smaller and smaller benefit. In sufficiently large samples, at
Γ = 1 the tests in both subgroups reject the null of no effect ratio with near certainty. As Γ
increases in this regime, the performance of the tests in both subgroups are dictated to a larger and
larger degree by the respective design sensitivities: Γ˜S = 1.65, and Γ˜NS = 2.33. This highlights the
importance of reduced heterogeneity of responses within pairs for increasing robustness to hidden
bias, echoing the findings of Rosenbaum (2005).
8. Summary
Assuming the validity of surgeon’s tendency to operate as an instrument, our effect estimates
indicate that surgery has an adverse, statistically significant, effect on both hospital length of stay
and presence of a complication within both the septic and non-septic subgroups, with a larger
estimated effect within the septic group. While the effect estimates for 30-day mortality indicate
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Figure 1. Sample size, heterogeneity, and the power of a sensitivity analysis. The
four plots show the power of the test against the null λ = 0 in the absence of
unmeasured confounding as a function of Γ for I = 200, 1000, 2000, and 10000. The
septic subgroup has nS = I pairs with a larger effect ratio and larger degree of
heterogeneity, while the non-septic has nNS = I/8 pairs, a smaller effect ratio and
a smaller degree of heterogeneity. Design sensitivities are Γ˜S = 1.65 and Γ˜NS = 2.33
respectively.
that surgery may also have an adverse effect, these results were not statistically significant at
α = 0.05 even assuming no hidden bias (Γ = 1). The complication outcome was robust to a
moderate degree of hidden bias: for both septic and non-septic patients, two individuals with the
same observed covariates would have to differ in their odds of being assigned to a high versus low
TTO surgeon by a factor of roughly 1.6 to overturn the findings of the study. For septic patients
a similar odds ratio discrepancy would be required to overturn the finding of an adverse effect on
hospital length of stay, while for non-septic patients the odds would have to differ by nearly 2.4.
38
This helps to frame the debate about what arguments against the validity of TTO as an instrument
would actually matter: if a pattern of hidden bias could not influence the odds of assignment of
surgeons to patients by this extent, it could not explain away the finding of an adverse effect.
The above conclusions required innovations in sensitivity analyses for instrumental variable de-
signs. Given surgery’s suspected variation in efficacy due to baseline patient characteristics we
developed a sensitivity analysis that does not require effect homogeneity. Instead, we show how a
sensitivity analysis for the effect ratio may proceed under essential heterogeneity, and indeed any
pattern of effect heterogeneity. We then developed variance estimators that can result in improved
sensitivity analyses when effects vary as a function of observed covariates. Further, we showed
how these improved variance estimators can form the basis of an exact test for whether effect
homogeneity holds, helpful in considering whether certain interpretations of an IV estimator are
warranted. Motivated by the finding that treatment effect estimates in the non-septic group were
more robust to hidden bias despite being of a smaller estimated magnitude, we showcased the role
of strong instruments and reduced within-pair effect variation for design sensitivity and the power
of a sensitivity analysis.
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Appendix A. Review
Notation Description
Zij Encouragement to treatment (1 yes, 0 no)
dij(1) & dij(0) Potential exposures for individual ij, i = 1, . . . n; j = 1, 2
yij(1) & yij(0) Potential outcomes
Yij & Dij Observed outcome and exposure
λ Effect ratio:∑n
i=1
∑2
j=1{yij(1)−yij(0)}∑n
i=1
∑2
j=1{dij(1)−dij(0)}
H
(λ0)
prop Null hypothesis under the proportional dose model
yij(1)− yij(0) = λ0{dij(1)− dij(0)} ∀ ij
H
(λ0)
weak Neyman’s weak null hypothesis on the effect ratio
λ = λ0
Definition
ζ
(λ0)
i = (Zi1 − Zi2){Yi1 − Yi2 − λ0(Di1 −Di2)}
LΓi = ζ
(λ0)
i −
(
Γ−1
Γ+1
)
|ζ(λ0)i |
µΓi = E(LΓi | F ,Z)
se(L¯Γ)
2 = 1n(n−1)
∑n
i=1(LΓi − L¯Γ)2
θΓ = Γ/(1 + Γ)
BΓi = VΓi|ζ(λ0)i | −
(
Γ−1
Γ+1
)
|ζ(λ0)i |
where VΓi = ±1; Pr(VΓi = 1) = θΓ and Pr(VΓi = −1) = 1− θΓ
ϕ(λ0)(α,Γ) = 1{L¯Γ/se(L¯Γ) ≥ G−1Γ (1− α)}
ϕ
(λ0)
Q (α,Γ) = 1{L¯Γ/se(L¯Γ; Q) ≥ G−1Γ (1− α; Q)}
GΓ(· Q): Studentized reference distribution generated by Algorithm 1
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A.1. Preliminaries. For each λ0, we define a new variable y
∗
ij(z) = yij(z) − λ0dij(z)(z = 0, 1)
which can be thought as the potential outcome adjusted for the dosage/exposure level received
for each individual ij. The adjusted potential outcomes y∗ij(1), y
∗
ij(0) are treated as if they are
the potential outcomes usually defined in the literature. Define τij = y
∗
ij(1) − y∗ij(0) and τ¯i =
(τi1 + τi2)/2. Then, τij can be considered as the effect of the treatment on the adjusted outcome
for individual ij, and τ¯i can be considered as the average treatment effect within pair i. Recall that
ζ
(λ0)
i = (Zi1 − Zi2){Yi1 − Yi2 − λ0(Di1 −Di2)}, which can be represented by (Zi1 − Zi2)(Y ∗i1 − Y ∗i2)
where Y ∗ij = y
∗
ij(1)Zij + y
∗
ij(0)(1 − Zij) is the observed “adjusted” outcome. This quantity can be
understood as the treated-minus-control paired “adjusted” outcome difference. Thus, ζ
(λ0)
i would
be an unbiased estimator for τ¯i in a randomized encouragement design, but may exhibit bias in the
presence of unmeasured confounders. Further define
ηi =
y∗i1(1) + y
∗
i1(0)
2
− y
∗
i2(1) + y
∗
i2(0)
2
,
which is the difference in the averages of the potential outcomes for individuals within a pair. Also,
recall that our sensitivity analysis model assumes, for each Γ,
1− θΓ ≤ pii = Pr(Zi1 = 1 | F ,Z) ≤ θΓ i = 1, . . . , n
where θΓ = Γ/(1 + Γ).
Asymptotics in the forthcoming discussions have in mind a single population F of increasing
size; randomness stems only from the assignments Z. The statement that H
(λ0)
weak holds in the limit
should, in reality, reflect the changing value of the effect ratio λ0n as the finite population Fn grows.
We will suppress both this dependence and conditioning upon F and Z for readability.
A.2. Regularity conditions.
Condition 1. There exist constants C > 0, µm and µa such that as n→∞,
n−1
n∑
i=1
|ηi| > C, n−1
n∑
i=1
η2i > C, (13)
n−2
n∑
i=1
η2i → 0, n−2
n∑
i=1
η4i → 0, n−2
n∑
i=1
τ¯4i → 0, (14)
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n−1
n∑
i=1
(2pii − 1)ηi → µm, n−1
n∑
i=1
pii|τ¯i + ηi|+ (1− pii)|τ¯i − ηi| → µa (15)
Condition 2. There exists a constant ν2 > 0 such that
n−1
n∑
i=1
pii(τ¯i + ηi)
2 + (1− pii)(τ¯i − ηi)2 → ν2. (16)
Appendix B. Proofs
B.1. Proposition 1. Given Conditions 1 and 2, Proposition 1 follows immediately from Theorems
1 and 2 of Fogarty (2019). We present a sketch of the proof here, the sketch slightly diverging from
the proof in Fogarty (2019) as here we merely establish asymptotic Type I error control under the
weak null.
The first component of the proof ignores the reference distribution GΓ(·), instead focusing on
the large-sample reference distribution Φ(·), the CDF of the standard Normal. Under Conditions
1 - 2:
(i) Under H
(λ0)
weak, the random variable
√
nL¯Γ converges in distribution to a Normal random
variable, whose expectation and standard deviation are unknown due to their dependence
on both the unknown potential outcomes and the unmeasured confounders.
(ii) Under H
(λ0)
weak and if the sensitivity model holds at Γ, E(
√
nL¯Γ) ≤ 0, and var(
√
nL¯Γ) ≤
nE{se(L¯Γ)2}, which tends to a limit as n→∞. That is, the unknown expectation is upper
bounded by zero, and there exists a sample-based standard error whose expectation upper
bounds the unknown variance.
(iii) The estimator se(L¯Γ)
2 converges in probability to its expectation, which is never smaller
than var(L¯Γ). For any  > 0, we have that limn→∞ pr(n× se(L¯Γ)2 +  ≤ var(
√
nL¯Γ)} → 0
Fixing α ≤ 0.5 and sending  to zero,
lim
n→∞pr
{
L¯Γ ≥ se(L¯Γ)Φ−1(1− α)
} ≤ lim
n→∞pr
{
L¯Γ ≥ sd(L¯Γ)Φ−1(1− α)
} ≤ α.
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The second component of the proof involves showing that Φ−1(1 − α) may be replaced by
G−1(1−α; 1n), the reference distribution generated by Algorithm 1 in the main text. Showing this
uses a technique from Hoeffding (1952) for assessing the limiting behavior of a permutation dis-
tribution, along with the variant of Slutsky’s theorem for randomization distributions from Chung
and Romano (2013). To generate a reference distribution, we use BΓi that stochastically dominates
LΓi under H
(λ0)
prop, of the form
BΓi = VΓi|ζ(λ0)i | −
(
Γ− 1
Γ + 1
)
|ζ(λ0)i |,
where VΓi = ±1 are independent across pairs, with pr(VΓi = 1) = θΓ. Let (
√
nB¯Γ,
√
nB¯′Γ) be
averages of BΓi and B
′
Γi formed with iid vectors (VΓ, V
′
Γ), such that (
√
nB¯Γ,
√
nB¯′Γ) are identically
distributed with covariance zero. We have
E(BΓi) = 0
var(BΓi) = E{var(BΓi | |ζ(λ0)i |}+ var{E(BΓi | |ζ(λ0)i |}
= 4θΓ(1− θΓ){pii(τ¯i + ηi)2 + (1− pii)(τ¯i − ηi)2},
where θΓ, pii, ηi, and τi are defined as in Section A.1. Further, under Conditions 1 and 2, (
√
nB¯Γ,
√
nB¯′Γ)
T
tends in distribution to a multivariate normal, with mean vector zero, correlation zero, and equal
variances ν2Γ = 4θΓ(1 − θΓ)ν2 where ν2 is defined in Condition 2. We also have that
√
nse(B¯Γ)
converges in probability to νΓ, such that (B¯Γ/se(B¯Γ), B¯
′
Γ/se(B¯
′
Γ))
T converge in distribution to iid
standard Normals. Recall that G(·; 1n) is the CDF of B¯Γ/se(B¯Γ). Combining the result of Hoeffd-
ing (1952), also given in Theorem 15.2.2 of Lehmann and Romano (2005), with Slutsky’s theorem
for randomization distributions (Chung and Romano 2013) yields that Φ−1(1−α) may be replaced
by G−1(1− α; 1n) while preserving the asymptotic level of the procedure, proving the result.
B.2. Proposition 2. Let D = {i : Yi1 + Yi2 = 1}, C0 = {i : Yi1 + Yi2 = 0}, C1 = {i : Yi1 + Yi2 = 2},
and θΓ = Γ/(1 + Γ). Under the sharp null, for any z ∈ Ω, McNemar’s test statistic can be written
as TD + |C1|, where TD = TD(z,Y) =
∑
i∈D
∑2
j=1 zijYij .
43
We now show that the studentized test statistic L¯Γ/se(L¯Γ) is a monotone increasing function of
TD over z ∈ Ω under the sharp null. First observe that under the sharp null, for any z ∈ Ω
nL¯Γ =
n∑
i=1
{(zi1 − zi2)(Yi1 − Yi2)− (2θΓ − 1)|Yi1 − Yi2|}
=
∑
i∈D
(zi1 − zi2)(Yi1 − Yi2)− (2θΓ − 1)|D|
=
∑
i∈D
{zi1Yi1 + zi2Yi2 − zi1(1− Yi1)− zi2(1− Yi2)} − (2θΓ − 1)|D|
= 2TD + |D| − (2θΓ − 1)|D| = 2(TD − θΓ|D|),
Meanwhile,
∑n
i=1 L
2
Γi can be expressed as
n∑
i=1
L2Γi = {1 + (2θΓ − 1)2}
n∑
i=1
(Yi1 − Yi2)2 − 2(2θΓ − 1)
n∑
i=1
(Zi1 − Zi2)(Yi1 − Yi2)|Yi1 − Yi2|
= {1 + (2θΓ − 1)2}|D| − 2(2θΓ − 1)(2TD + |D|)
= {1− (2θΓ − 1)2}|D| − 2(2θΓ − 1){2(TD − θΓ|D|)},
and n(n− 1)se(L¯Γ)2 as
n(n− 1)se(L¯Γ)2 = {1− (2θΓ − 1)2}|D| − 2(2θΓ − 1){2(TD − θΓ|D|)} − n−1{2(TD − θΓ|D|)}2.
Let a = n−1, b = 2(2θΓ − 1), c = {1− (2θΓ − 1)2}|D|, and x = 2(TD − θΓ|D|). We then have
L¯Γ
se(L¯Γ)
∝ x√
c− bx− ax2 ,
and to complete the proof it is sufficient to show that this function has a positive first derivative
with respect to x over its domain, 2θΓ|D| ≤ x ≤ (2 + 2θΓ)|D|.
Differentiating yields
∂
∂x
L¯Γ
se(L¯Γ)
∝
√
c− bx− ax2 + bx/2+ax2√
c−bx−ax2
c− bx− ax2 ,
and we want to show that this is always positive, which amounts to showing c ≥ (b/2)x. Maximizing
the right hand side over x, this means showing {1 − (2θΓ − 1)2}|D| ≥ (2θΓ − 1)(2|D| − 2θΓ|D|),
which does hold. L¯Γ/se(L¯Γ) is monotone increasing in 2(TD − θΓ|D|), and hence also in TD + |C1|,
44
which is McNemar’s test. The test statistics have perfect rank correlation over z ∈ Ω, and hence
are equivalent.
B.3. Proposition 3. Recall that L˜Γi = LΓi/
√
1− hii, µ˜Γi = E(L˜Γi) and µ˜Γ = E(L˜Γ). Define
Λ as the covariance matrix for L˜Γi, and note that Λ is a diagonal matrix, and the i-th diagonal
element of Λ is Λii = var(L˜Γi) = var(LΓi)/(1− hii)
Using results on expectations of quadratic forms, E{se(L¯Γ; Q)2} can be computed as
E{se(L¯Γ; Q)2 | F ,Z} = 1
n2
E
(
L˜TΓ(I−H)L˜Γ
)
=
1
n2
[
tr{(I−H)Λ}+ µ˜TΓ(I−H)µ˜Γ
]
=
1
n2
n∑
i=1
(1− hii)Λii + 1
n2
µ˜TΓ(I−H)µ˜Γ
=
1
n2
n∑
i=1
var(LΓi | F ,Z) + 1
n2
µ˜TΓ(I−H)µ˜Γ
= var(L¯Γ) +
1
n2
µ˜TΓ(I−H)µ˜Γ ≥ var(L¯Γ)
The last inequality holds because the matrix (I−H) is positive semidefinite.
B.4. Proposition 4. Define HQreg = Qreg(Q
T
regQreg)
−1QTreg and H1n = 1n(1Tn1n)−11n. We
prove the result for a general matrix Q with a fixed number of columns for all n. Specifically, under
suitable regularity conditions will prove
n× se(L¯Γ; Q)2 − var(
√
nL¯Γ)
p→ lim
n→∞
1
n
µTΓ (I−HQ)µΓ.
The proof follows that of Theorem 1 in Fogarty (2018). The following regularity conditions are
considered to prove Proposition 4.
Condition 3. Assume that Q is a (n× k) matrix with k fixed. The following conditions hold for
each Γ ≥ 1.
(1) (Bounded Fourth Moments).
There exists a C1 < ∞ such that 1n
∑n
i=1E(L
4
Γi) < C1 and
1
n
∑n
i=1Q
4
iq < C1 for q =
1, . . . , k. For the specification of Qreg = (1, X¯), the term Q
4
iq can be replaced by x¯
4
iq.
(2) (Existence of Population Moments).
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– 1n
∑n
i=1 µΓi,
1
n
∑n
i=1 µ
2
Γi, and var(
√
nL¯Γ) =
1
n
∑n
i=1 var(LΓi) converge to finite limits as
n→∞.
– 1n
∑n
i=1 µΓiQiq converges to a finite limit for q = 1, . . . , k as n→∞.
– 1nQ
TQ converges to a finite, invertible matrix as n→∞.
Define κΓq = lim
n→∞
1
n
∑n
i=1 µΓiQiq. This is the limit of the sum of all elements in the qth column
of µTΓQ. Let κΓ as the vector of length k containing limits κΓq, q = 1, . . . , k. Also, define ΣQ =
lim
n→∞n
−1QTQ.
Consider the following lemma:
Lemma 1. Under Condition 3,
(1) n−1
∑n
i=1 LΓiQiq converges in probability to limn→∞n
−1∑n
i=1 µΓiQiq.
(2) hii → 0
(3) n−1
∑n
i=1 L
2
Γi
p→ lim
n→∞n
−1∑n
i=1{µ2Γi + var(LΓi)}
Proof of Lemma 1.
Proof of (1). Since E(LΓi) = µΓi, E(n
−1∑n
i=1 LΓiQiq) → limn→∞n
−1∑n
i=1 µΓiQiq. The variance
var(n−1
∑n
i=1 LΓiQiq) goes to zero,
var(n−1
n∑
i=1
LΓiQiq) =
1
n2
n∑
i=1
Q2iqvar(LΓi)
≤ 1
n2
{
n∑
i=1
var(LΓi)
2
}1/2{ n∑
i=1
(Qiq)
4
}1/2
≤ 1
n
{
1
n
n∑
i=1
E(L4Γi)
}1/2{
1
n
n∑
i=1
(Qiq)
4
}1/2
→ 0
Proof of (2). Since hii can be represented by Q
T
i (Q
TQ)−1Qi and Qi does not vary with n, from
ΣQ = lim
n→∞n
−1QTQ, we have
lim
n→∞hii = limn→∞n
−1QTi Σ
−1
Q Qi = 0.
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Proof of (3). This is a straightforward application of Chebyshev’s inequality. Observe that
var(n−1
∑n
i=1 L
2
Γi) ≤ n−2
∑n
i=1E(L
4
Γi) < n
−1C1 → 0, such that average n−1
∑n
i=1 L
2
Γi converges in
probability to its expectation.

For any Q, n× se(L¯Γ; Q)2 is
n× se(L¯Γ; Q)2 = 1
n
(
L˜TΓ (I−HQ)L˜Γ
)
=
1
n
(
L˜TΓ L˜Γ − L˜TΓQ(QTQ)−1QT L˜Γ
)
.
From Lemma 1, the above expression converges in probability to
1
n
L˜TΓ L˜Γ
p→ lim
n→∞
1
n
µTΓµΓ + limn→∞var(
√
nL¯Γ)
1
n
L˜TΓQ(Q
TQ)−1QT L˜Γ
p→ κTΓΣ−1Q κΓ = limn→∞
1
n
µTΓHQµΓ.
Therefore, we have
n× se(L¯Γ; Q)2 − var(
√
nL¯Γ)
p→ lim
n→∞
1
n
µTΓµΓ − limn→∞
1
n
µTΓHQµΓ = limn→∞
1
n
µTΓ (I−HQ)µΓ.
Also, since the coefficient R2 in a regression of µΓ on Qreg has the representation
R2 = 1− µ
T
Γ (1−HQreg)µΓ
µTΓ (1−H1n)µΓ
,
we have
n× se(L¯Γ; Qreg)2 − var(
√
nL¯Γ)
n× se(L¯Γ; 1n)2 − var(
√
nL¯Γ)
p→ 1−R2.
B.5. Proposition 5. Assume that the pair index i is re-ordered according to the pairs of pairs.
For instance, for the qth of n/2 pairs of pairs, we assume that i = 2q−1 and i = 2q, q = 1, . . . , n/2,
are in the qth pair of pairs. Then, the n × (n/2) matrix QPoP and the n × n matrix HQPoP are
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represented by
QPoP =

1
1
1
1
...
1
1

, HQPoP =

1/2 1/2
1/2 1/2
1/2 1/2
1/2 1/2
. . .
1/2 1/2
1/2 1/2

.
Using this representation of Q, the vector (I−HQPoP )L˜Γ contains residuals. The ith component
of this vector is (LΓi − LΓJ (i))/
√
2, where J (i) is index of the pair that was matched with to ith
pair such that J (J (i)) = i. Since (I−HQPoP ) is idempotent, the variance estimator se(L¯Γ; QPoP )2
can be represented by the equation (5) in the main manuscript. Also, from Proposition 3, the bias
E[se(L¯Γ; QPoP )
2 | F ,Z]− var(L¯Γ | F ,Z) is
1
n2
µ˜TΓ (I−HQPoP )µ˜Γ =
1
n2
{
(I−HQPoP )µ˜Γ
}T
(I−HQPoP )µ˜Γ
=
1
2n2
n∑
i=1
(µΓi − µΓJ (i))2.
The last equality stems from the fact that the ith component of (I−HQPoP )µ˜Γ is (µΓi−µΓJ (i))/
√
2.
B.6. Proposition 6. Recall that, for some matrix Q, the new testing procedure is defined as
ϕ
(λ0)
Q (α,Γ) = 1{L¯Γ/se(L¯Γ; Q) ≥ G−1Γ (1− α; Q)}
where GΓ(·; Q) is the distribution of B¯Γ/se(B¯Γ; Q) given |ζ(λ0)| and is itself random over z ∈ Ω.
As in the proof of Proposition 1, we first establish
lim
n→∞pr{L¯Γ/se(L¯Γ; Q) ≥ Φ
−1(1− α)} ≤ α,
This holds under Condition 3 for Qreg (or, more generally, for matrices Qreg whose number of
columns do not grow with n), as under those conditions the standard errors have limits in prob-
ability. For QPoP , observe that the number of columns is n/2, such that Proposition 3 does not
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apply. It is sufficient to show that for any  > 0,
lim
n→∞pr{n× se(L¯Γ; QPoP )
2 ≤ n× var(L¯Γ)− } = 0
The estimator n× se(L¯Γ; QPoP )2 has expectation
n× E{se(L¯Γ; QPoP )2} = n× var(L¯Γ) + 1
2n
n∑
i=1
(µΓi − µΓJ (i))2.
The term (2n)−1
∑n
i=1(µΓi − µΓJ (i))2 is nonnegative, and Conditions 1-2 imply that n × var(L¯Γ)
tends to a (positive) limit. We have
var{n× se(L¯Γ; QPoP )2} ≤ 16n−2
n∑
i=1
E(L4Γi),
which tends to zero under part (1) of Condition 3. Through Chebyshev’s inequality, we then have
for any  > 0
pr
{
n× se(L¯Γ; QPoP )2 − n× var(L¯Γ) ≤ −
}
≤ pr
{
n× se(L¯Γ; QPoP )2 − n× var(L¯Γ)− (2n)−1
n∑
i=1
(µΓi − µΓJ (i))2 ≤ −
}
≤ pr
{∣∣∣∣∣n× se(L¯Γ; QPoP )2 − n× var(L¯Γ)− (2n)−1
n∑
i=1
(µΓi − µΓJ (i))2
∣∣∣∣∣ ≥ 
}
≤ var{n× se(L¯Γ; QPoP )2}/2 → 0,
establishing
lim
n→∞pr{L¯Γ ≥ se(L¯Γ; Q)× Φ
−1(1− α)}} ≤ lim
n→∞pr{L¯Γ ≥ sd(L¯Γ)× Φ
−1(1− α)}} ≤ α
with both Q = Qreg and Q = QPoP .
Next, we show that Φ−1(1− α) may be replaced with G−1(1− α; Q) for either of these choices
for Q. The proof differs from the analogous portion of Proposition 1 only in that we must instead
establish that
n× se(B¯Γ; Q)2 p→ ν2Γ
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for Q 6= 1n. This can be proved by using E{se(B¯Γ; Q)2} = var(B¯Γ) for any Q and that var{n ×
se(B¯Γ; Q)
2} → 0. Recall that se(B¯Γ; Q)2 = 1n2 B˜TΓ (I −HQ)B˜Γ where B¯Γi = BΓi√1−hii . Define ΛΓ be
the covariance matrix of B˜Γ, and ΛΓii be the ith diagonal element of ΛΓ. We have E(BΓi) = 0 and
ΛΓii =
1
1−hiivar(BΓi).
Lemma 2. E{se(B¯Γ; Q)2} = var(B¯Γ)
Proof. E{se(B¯Γ; Q)2} can be computed by
E[se(B¯Γ; Q)
2] =
1
n2
E[B˜TΓ (I−HQ)B˜Γ]
=
1
n2
tr[(I−HQ)ΛΓ] + E(B˜Γ)T (I−HQ)E(B˜Γ)
=
1
n2
tr{(I−HQ)ΛΓ}
=
1
n2
n∑
i=1
var(BΓi) = var(B¯Γ)

The second to last line follows from E(BΓi) = 0 for all i, as the random variable BΓi behaves as
though the proportional dose model holds under the worst-case assignment probabilities. For Qreg,
by using the fact that hii → 0 and assuming 1n
∑n
i=1E(B
4
Γi) is bounded, n×var{se(B¯Γ; Qreg)2} → 0
through an analogous argument to that in Proposition 4. Assuming n−1
∑n
i=1E(B¯Γi) is bounded
also gives that n × var{se(B¯Γ; QPoP )2} → 0, such that n × se(B¯Γ; QPoP )2 p→ ν2Γ. With this
established, the proof that the quantile G−1(1− α; Q) with Q = Qreg or QPoP , may be employed
is analogous to Proposition 1.
To prove that ϕ
(λ0)
Q (α,Γ) with Q = Qreg or Q = QPoP is both less conservative under the null
and more powerful under the alternative than the test using the conventional standard error, it
suffices to show that for any  > 0 and for either of these choices Q,
lim
n→∞pr[n×
{
se(L¯Γ; 1n)
2 − se(L¯Γ; Q)2
} ≤ −] = 0
Observe that
pr[n
{
se(L¯Γ; 1n)
2 − se(L¯Γ; Q)2
} ≤ −]
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= pr
(
n
[
se(L¯Γ; 1n)
2 − E{se(L¯Γ; 1n)2}+ E{se(L¯Γ; 1n)2} − se(L¯Γ; Q)2
] ≤ −)
≤ pr (n [se(L¯Γ; 1n)2 − E{se(L¯Γ; 1n)2}] ≤ −)+ pr (n [E{se(L¯Γ; 1n)2} − se(L¯Γ; Q)2] ≤ −)
The first probability tends to zero, as under Conditions 1-2 the conventional standard error con-
verges in probability to its expectation. For Qreg, the second probability also tends to zero under
Condition 3 through a proof analogous to Proposition 4. For QPoP , we need conditions to further
ensure that
lim
n→∞
{
1
n
n∑
i=1
(µΓi − µ¯Γ)2 − 1
2n
n∑
i=1
(µΓi − µΓJ (i))2
}
≥ 0.
In a sense, the required condition is that pairing pairs on the basis of observed covariates is effectively
creating pairs of pairs with similar expectations. Observe that if we randomly paired the pairs
without any consideration of similarity on observed covariates, the difference in these two terms
would equal zero. Regularity conditions are needed to preclude pairings of pairs yielding a worse
alignment of expectations than what would be expected under random pairings of pairs. The
sufficient condition reflecting this natural requirement takes the form
lim
n→∞
1
2n
n∑
i=1
(µΓi − µ¯Γ)(µΓJ (i) − µ¯Γ) ≥ 0.
See Abadie and Imbens (2008) for a discussion of sufficient conditions in a superpopulation formula-
tion where the potential outcomes are viewed as random but the covariates as fixed, wherein natural
connections between our sufficient condition and Lipschitz conditional expectation and conditional
variance functions are explored.
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